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Overview  
This volume is separated into three parts: 
  Part 1: Literature review. A systematic review and meta-analysis of twelve 
randomised  controlled  trials  that  examined  the  efficacy  of  psychological 
treatment for  vaginal pain. The aim was to understand whether efficacy  of 
treatment  differed  for  vaginal  pain  defined  as  medical  or  psychiatric  in 
aetiology. Differences and similarities in efficacy were examined on outcomes 
of  pain  and  sexual  function.  Effectiveness  of  psychological  treatment  was 
found to be comparable regardless of aetiology, indicating that this distinction 
may not be helpful for informing treatment decisions. 
  Part  2:  Empirical  paper.  A  mixed  methods  study  evaluated  a  new 
computerised  programme  for  six  women  with  vaginismus.  Change  in  pain-
related  fear,  penetration  behaviour  and  pain  intensity  was  quantitatively 
assessed.  Interviews  were  used  to  qualitatively  explore  acceptability  and 
change. Pain-related fear and pain intensity reduced over the course of the 
programme;  successful  penetration  increased.  The  programme  was 
experienced  as  convenient,  gradual,  and  supportive,  with  moments  of 
frustration at progress. The programme also had a positive influence on self-
awareness,  confidence,  normalisation,  and  approach  behaviours,  with 
exposure attributed as the most difficult but important aspect of change. 
  Part 3: Critical appraisal. An appraisal of methodology used in the empirical 
study, discussing the potential biases encountered with research allegiance.   4 
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ABSTRACT 
Background:  Vaginal  pain  is  experienced  in  numerous  health  conditions. 
Classifying these conditions using aetiological factors is often imprecise, but 
vaginal pain is typically defined as having a medical or psychiatric cause. The 
primary  distinction  between  the  categories  is  the  presence  or  absence 
(respectively) of an assumed physiological cause. Whilst causes of pain vary, 
commonalities in response to vaginal pain exist across conditions, including 
sexual  behaviour,  and  emotional  and  cognitive  experiences.  Exploring  how 
medically and psychiatrically defined vaginal pain responds to psychological 
treatment could help to understand further similarities and differences of the 
conditions.  Aim:  To  examine  the  combined  and  relative  efficacy  of 
psychological  treatments  for  vaginal  pain  problems  defined  as  medical  or 
psychiatric on outcomes of pain and sexual function. Method: A systematic 
search of EMBASE, Medline, PsycINFO and CINAHL was undertaken. Twelve 
randomised controlled trials were included of which eleven provided data that 
were entered into a meta-analysis. Standardised mean differences and odds 
ratios were used to calculate effects. Effect sizes for individual psychological 
trial  arms  were  also  calculated  to  compare  efficacy  between  vaginal  pain 
types. Results: The meta-analysis revealed no significant differences when 
comparing psychological treatments to medical and psychological alternatives 
for  all  vaginal  pain  disorders,  on  outcomes  of  pain  and  sexual  function. 
Individual effect sizes for psychological treatment arms were similar for both 
vaginal  pain  types.  Conclusions:  Effectiveness  of  psychological  treatment 
was  comparable  for  vaginal  pain  conditions  regardless  of  their  medical  or 
psychiatric categorisation, indicating that the aetiological distinction may not 
be  helpful.  This  could  have  clinical  implications  for  the  type  of  treatments 
offered for vaginal pain. Further research in this area is needed to support 
these findings.  10 
 
 
INTRODUCTION 
There  are  numerous  vaginal  pain  disorders  that  interfere  with  sexual 
functioning.  Some  of  these  are  defined  as  pain  disorders  with  medical 
aetiology  and others as sexual dysfunctions  with  psychiatric  aetiology.  The 
definitions  will  be  explored  in  an  attempt  to  understand  their  unique  and 
shared characteristics.   
 
Medically defined vaginal pain 
Vulvodynia  is  a  term  used  to  describe  chronic  pain  of  the  vulvar  (external 
genital region). Vulvodynia can be broken down into  subtypes: generalised 
(pain across entire vulva), localised (pain in specific area of vulva), provoked 
(pain on contact), and unprovoked (pain without contact). Combinations of the 
subtypes exist and terminology is variable, e.g. vestibulodynia is a term used 
to  describe  pain  localised  to  the  vestibule.  Vulvodynia  is  not  diagnosed  if 
certain  conditions  are  present  that  cause  pain,  such  as  particular  skin 
disorders  or  sexually  transmitted  infections.  However,  vulvodynia  is  still 
medically defined, because it is assumed to have underlying organic causes. 
Interestingly, these causes are largely unknown and it is widely accepted that 
the aetiology of vulvodynia remains unidentified (Lonkey, Edwards, Gunter & 
Haefner, 2011; Lotery, McClure & Galask, 2004). A number of possibilities 
have  been  suggested,  including  genetic  vulnerabilities,  immune  factors, 
hormonal imbalances, and alternation in the sensitivity of nerves (Haefner et 
al., 2005); factors that are not readily identifiable. This can also be the case 
with ‘medically unexplained pain’ conditions, such as fibromyalgia, which  is 
often diagnosed in the absence of a clear causal explanation. This does not 
imply that pain is caused by non-medical or psychological factors, but that the 
clinical tools available are not able to identify a cause. Vulvodynia may follow 11 
 
infection, such as recurrent thrush, even after it has been successfully been 
treated  (Paavonen,  1995).  But  often  there  is  no  identifiable  trigger.  A 
population  survey  showed  that  the  onset  of  vulvodynia  was  attributed  to 
situational factors, such as tampon insertion or intercourse, suggesting that 
pain pre-existed attempts at penetration. Interestingly higher levels of stress 
were  found  in  women  who  developed  vulvodynia  than  those  who  did  not, 
which  could  point  towards  a  biopsychological  understanding  of  pain  onset 
(Sutton, Bachmann, Arnold, Rhoads & Rosen, 2008).  
 
Viewed  medically,  vulvodynia  is  diagnosed  using  physical  indicators.  For 
example,  provoked  localised  vulvodynia  can  be  assessed  using  Friedrich’s 
(1987) three criteria: 1) pain on vestibular contact or attempted penetration, 2) 
tenderness  when  localised  pressure  is  applied  to  the  vestibule  (vaginal 
opening), and 3) vestibular erythema (redness). Classified as a pain disorder, 
its impact on functioning is not necessary for a diagnosis; however, the pain 
can have a considerable impact on aspects of life, including sexual function. 
Reasons for impaired sexual functioning may appear obvious, particularly in 
the provoked subtypes. Pain can interfere with intercourse, reduce arousal, 
diminish  desire,  and  elicit  fear  and  avoidance  behaviours  (Hallam-Jones, 
Wylie, Osborne-Cribb, Harrington & Walters, 2001; Masheb, Lozano-Blanco, 
Kohorn,  Minkin  &  Kerns,  2004).  Dyspareunia  (pain  on  intercourse)  is  a 
defining  characteristic  of  provoked  vestibulodynia  (Goldstein,  Pukall  & 
Goldstein,  2009).  In  a  medical  sense,  dyspareunia  and  vestibulodynia  are 
seen as part of the same condition; however, when a psychiatric classification 
of dyspareunia is introduced the picture becomes more ambiguous.  
 
Psychiatrically defined vaginal pain 12 
 
DSM-IV-TR  (APA,  2000)  criteria  are  used  in this  review,  as  it  commenced 
before  the  publication  of  the  DSM-5  (APA,  2013).  The  DSM-5  revised 
classifications of vaginal pain disorders, implications of which are discussed 
below.  
The  DSM-IV-TR  defined  sexual  dysfunction  as  an  interference  with 
sexual  responsivity  or  pleasure,  causing  marked  distress  or  interpersonal 
difficulty. The sexual dysfunctions span numerous areas of sexual response 
(e.g.  arousal,  desire,  orgasm),  but this  review  focuses  on the two  that  are 
associated  with  sexual  pain:  dyspareunia  and  vaginismus.  Dyspareunia  is 
described  as  ‘recurrent  or  persistent  genital  pain  associated  with  sexual 
intercourse’. The criteria specify that dyspareunia is not caused exclusively by 
effects of substances or a general medical condition. Vaginismus is described 
as ‘recurrent or persistent involuntary spasm of the musculature of the outer 
third of the vagina that interferes with sexual intercourse’. Similarly, this is not 
accounted for by medical causes. This definition does not explicitly mention 
pain;  however,  it  is  categorised  in  the  sexual  pain  section.  Therefore,  the 
distinguishing  criterion  between  dyspareunia  and  vaginismus  is  a  vaginal 
muscle spasm, the certainty of which has been disputed.  
Several reviews have concluded that evidence to support the existence 
of a vaginal spasm is weak (Binik, 2005, 2010a, 2010b). This was evidenced 
through  experimental  research,  which  found  no  differences  between 
vaginismus and dyspareunia on a range of measures, including: penetration of 
a  finger,  muscle  tension  or  pain  during  intercourse  (De  Kruiff,  Ter  Kuile, 
Weijenborg & van Lankveld, 2000). Women with vaginismus reported more 
difficulty with sexual intercourse and women with dyspareunia reported more 
pain on examination, but these differentiating factors are not reflected in DSM-
IV  criteria.  The  sample  size  in  this  study  was  small;  therefore,  subtle 
dissimilarities  may  have  been  detected  with  more  power.  Other  empirical 13 
 
research found that gynaecologists could detect greater muscle tension and 
more  frequent  vaginal  spasms  in  vaginismus,  compared  with  dyspareunia 
(from vestibulodynia) and healthy controls. However, only 28% of women with 
vaginismus exhibited the spasm on penetration. Interestingly, it was fear and 
avoidance  behaviours  that  were  more  frequently  reported;  73%  in  the 
vaginismus group refused electromyographic sessions (measure of activity in 
vaginal muscle) compared with 0% in dyspareunia and control group. Women 
with  vaginismus  were  also  rated  significantly  higher  by  gynaecologists  on 
defensive  behaviours  that  interfered  with  the  examination  (Reissing  et  al., 
2004). This fits with other research that has identified specific cognitive and 
behavioural  (as  opposed  to  physical)  elements  of  vaginismus,  such  as 
increased  catastrophising  of  pain,  negative  self-image,  feelings  of  sexual 
disgust, fears of intimacy and loss of control (Borg, Peters, Schultz & de Jong, 
2012; de Jong, Overveld, Schultz, Peters & Buwalda, 2009). Such cognitions 
have been attributed to the cause of vaginismus (Reissing, 2012),  as they 
would precede anticipatory anxiety and consequent muscle tension found in 
vaginismus. But these cognitions are not reflected in the DSM and are more 
consistent  with  chronic  pain  presentations.  The  inconclusiveness  of  the 
literature has led to a change in the diagnostic criteria in the most recent DSM-
5 publication (APA, 2013).  
 
Integrating diagnoses  
The DSM-5 (APA, 2013) no longer separates vaginismus and dyspareunia; 
instead it has increased overlap between them by introducing a more inclusive 
diagnosis.  Genito-Pelvic  Pain/Penetration  Disorder  (GPPPD)  incorporates 
both diagnoses into one classification (see Box 1). GPPPD consists of four 
broad domains: penetration, pain, fear and muscle tension, each of which can 
be assessed separately. For example, women may experience pain but still 14 
 
manage  penetration,  or  they  could  experience  minimal  pain  during 
penetration, but have a marked fear of penetration. These domains do not rely 
so  heavily  on  the  assessment  of  aetiological  factors  (such  as  a  spasm); 
instead the focus is on symptomatology and impact on functioning.  
 
Box 1 
DSM-5 (APA, 2013) criteria for Genito-Pelvic Pain/Penetration Disorder 
(GPPPD) 
 
A minimum of one symptom is needed to be present for a diagnosis, therefore 
GPPPD  should  capture  a  wider  range  of  vaginal  pain  problems.  The 
previously mentioned  vulvodynia subtypes  could also overlap  with GPPPD. 
For  example,  women  with  provoked  vulvodynia  experience  pain  on  touch, 
which is likely to be aggravated during sexual activity. This may interfere with 
penetration and may lead to a marked fear of sexual activity, all of which is 
present in the absence of a known medical cause (Paavonen, 1995). It may 
not have been the intention of the DSM-5 classification to include vulvodynia, 
  Persistent or recurrent difficulties with one or more of the following: 
1) Vaginal penetration during intercourse  
2)  Marked  vulvovaginal  or  pelvic  pain  during  vaginal  intercourse  or  penetration 
attempts 
3)  Marked  fear  of  or  anxiety  about  vulvovaginal  or  pelvic  pain,  in  anticipation  of, 
during, or as a result of vaginal penetration 
4) Marked tensing or tightening of the pelvic floor muscles during attempted vaginal 
penetration.  
  Symptoms have persisted for a minimum of 6 months. 
  Symptoms cause clinically significant distress in the individual. 
  The sexual dysfunction is not better explained by a nonsexual mental disorder or as 
a consequence of severe relationship distress or other significant stressors and is 
not attributable to the effects of substance/medication or another medical condition. 15 
 
but  due  to  the  overlap  in  symptomatology,  GPPPD  is  a  widely  inclusive 
classification that disregards aetiology.  
 
Theory of pain 
Pain theory increasingly recognises chronic pain as a disorder with common 
biological  and  psychological  features  regardless  of  where  the  pain  is  felt 
(Tracey & Bushnell, 2009). Melzack and Wall’s (1965) pioneering pain-gate 
model understands pain to occur through two main processes: 1) a neuronal 
response, in terms of noxious sensory input received and processed at the 
dorsal horn, and 2) the top-down influence on pain at the spinal level, through 
psychological processes, such as attention, mood and memory.  
The  neuronal  response  in  chronic  pain  is  often  explained  by  the 
concept  of  sensitisation.  Sensitisation  is  the  amplification  of  neuronal 
excitability, which leads to a greater number of signals being processed as 
pain at the dorsal horn. This process has been identified both centrally (in 
central nervous system) and peripherally (in the nerve fibres) in vulvodynia 
(Bohm-Starke, 2010; Tympanidis, Terenghi & Dowd, 2003). Changes in the 
central nervous system have also been identified in vaginismus (Frasson et 
al., 2009), but evidence for this is slim compared to vulvodynia.  
Psychological  components  of  provoked  vestibulodynia  have  been 
integrated into a biopsychological model to explain the influence of vulval pain 
on  sexual  dysfunction  (Basson,  2012).  The  model  suggests  that  stress  in 
combination  with  numerous  premorbid  psychological  factors  (e.g.  anxiety, 
depression, harm avoidance, hypervigilance and traits of perfectionism) can 
induce  neuronal  changes  in  the  form  of  sensitisation.  In  turn,  the  pain  is 
maintained or heightened by acquired risk factors, such as beliefs of sexual 
inadequacy and diminished sexual motivation. This dynamic reciprocal model 
highlights  how  biological  and  genetic  factors  interact  with  behavioural  and 16 
 
cognitive factors. Similar top-down influences have been found in women with 
vaginismus (Borg et al., 2012). It could be conceived that women, for example, 
with  pre-morbid  anxiety  or  harm  avoidance  could  be  more  vulnerable  to 
developing  vaginismus  if  they  encounter  difficult  sexual  experiences  or 
develop negative self-beliefs.  
Anxiety and fear-avoidance models can be applied to pain processing 
irrespective of pain aetiology. Leeuw, Goossens, Linton, Crombez, Boersma 
and Vlaeyen (2007) developed a model that described how pain is maintained 
by avoidance due to a range of unhelpful cognitive strategies. These included: 
catastrophising about pain (e.g. imagining self as bedbound or paralysed by 
pain); pain-related anxiety (e.g. hypervigilance to unpleasant sensations); and 
pain-related fear (threatened by anticipation of pain). Continual perceptions of 
threat and feelings of anxiety can increase excitability and sensitivity of the 
pain  system  (Norton  &  Asmundson,  2004).  Avoidance  behaviours  diminish 
opportunities to challenge perceived threat and prevent physical benefits such 
as  muscle  strength.  In  terms  of  vaginal  pain,  these  concepts  also  apply 
(Payne, Binik, Amsel & Khalifé, 2005). Whether diagnosed with vaginismus, 
dyspareunia or vulvodynia, pain can increase threat perception, anxiety and 
avoidance, all of which could be modified using psychological techniques.  
 
It  is  not  only  anxiety  that  influences  pain;  general  negative  affect  can 
exacerbate  pain  (Janssen,  2001).  Experimental  studies  have  demonstrated 
that  pain  is  perceived  as  significantly  worse  when  a  sad  mood  is  induced 
(Boettger, Schwier & Bär, 2011; Tang, Salkovskis, Hodges, Wright, Hanna & 
Hester,  2008).  This  is  supported  by  neuroimaging  studies  that  have  found 
increased activation in the anterior cingulate cortex and the amygdala (both 
involved in the emotional processing of pain), suggesting an exacerbation of 
pain  perception  when  accompanied  by  sadness  (Berna,  Leknes,  Holmes, 17 
 
Edwards, Goodwin & Tracey, 2010; Yoshino et al., 2010). Berna et al., (2010) 
developed a model that could accurately predict severity of pain experience 
using pain-based cognitions as an independent variable. This provides neural 
evidence for pain mechanisms responding to mood and cognition.   
 
So far, the evidence suggests there may be physiological distinctions between 
medically defined conditions (vulvodynia subtypes) and psychiatrically defined 
vaginal pain conditions (vaginismus & dyspareunia). However, there is less 
evidence  for  psychological  distinctions;  similar  cognitive,  behavioural  and 
emotional responses are found across pain conditions.  
This raises the  clinical  question:  would medically and psychiatrically 
defined vaginal pain conditions respond similarly or differently to psychological 
interventions? For example, if the cause of sexual avoidance is localised pain, 
it could be hypothesised that psychological intervention may not be effective. 
However, addressing fear of pain may activate descending inhibitory pathways 
that  in  turn  act  on  localised  pain.  Light  can  be  cast  on  this  question  by 
examining how the varying conditions respond to psychological intervention. 
While this cannot establish which aspects of the conditions are the same or 
distinct, it can add to the existing evidence which bears on the classification of 
the disorders and how they are best treated. 
 
Psychological interventions for vaginal pain 
Treatments  for  vaginal  pain  disorders  have  tended  to  correspond  with  the 
medical versus psychiatric distinction. Treatment for vaginismus has primarily 
been psychological; in a systematic review of vaginismus, the large majority of 
trials  evaluated  systematic  desensitisation  or  cognitive-behavioural  therapy 
(Melnik,  Hawton  &  McGuire,  2012).  Some  medical  interventions  for 18 
 
vaginismus have been evaluated, such as botox and bupivacaine injections 
which  aim  to  minimise  pain  (Pacik,  2011).  Dyspareunia  has  tended  to  be 
treated  medically,  because  it  is  commonly  a  secondary  diagnosis  to 
vulvodynia  (rather  than  a  discrete  sexual  dysfunction).  In  turn,  treatment 
typically  targets  the  pain  itself  rather  than  the  impact  the  pain  causes  on 
penetration  (Binik,  2005).  In  a  review  of  vestibulodynia  that  examined 
dyspareunia  outcomes,  almost  all  studies  evaluated  medication,  surgery  or 
physiotherapy  (Andrews,  2011).  The  assumption  could  be  that  if  the  pain 
reduces so too will the dyspareunia. The majority of effectiveness research for 
vulvodynia  has  examined  medical  treatment,  but  some  psychological 
interventions (exposure, CBT & mindfulness) have been examined (Murina, 
Berniorio & Palmiotto, 2008; Bergeron et al., 2001; Brotto, Basson, Carlson & 
Zhu, 2013) and show promising effects.  
 
Aims of review  
Vaginal pain conditions generally get treated medically or psychologically in 
accordance with their definitions, but the evidence had not been evaluated in a 
systematic way. If psychological treatments are found to be effective for both 
medically  and  psychiatrically  defined  conditions  on  outcomes  of  pain  and 
sexual  function,  this  could  imply  that  aetiological  distinctions  are  not  so 
important, and that behavioural, emotional and cognitive response to pain are 
comparable. This review brings the evidence together by exploring the efficacy 
of psychological interventions for an inclusively-defined group of vaginal pain 
problems. Previously, one systematic review has examined the effectiveness 
of CBT for a more inclusive group of vaginal pain problems, and concluded it 
was a  worthwhile treatment for  improving sexual function (LoFrisco, 2011). 
Taking  this  further,  the  current  review  will  combine  evidence  for  all 19 
 
psychological  interventions for  medically  and  psychiatrically  defined  vaginal 
pain. This will help to answer the following review questions:  
1.  How  effective  are  psychological  interventions  for  medically  and 
psychiatrically defined vaginal pain on outcomes of pain and sexual 
functioning? 
2.  Is  there  a  difference  in  effectiveness  of  psychological  treatment 
between  medically  and  psychiatrically  defined  vaginal  pain  on 
outcomes of pain and sexual functioning?  
 
METHOD 
Search strategy  
A  search  of  the  literature  was  undertaken  in  August  2013  using  multiple 
electronic databases (EMBASE 1974- Aug 2013; Medline 1946- Aug 2013; 
PsycINFO 1967- Aug 2013; CINAHL 1981- Aug 2013). These searches were 
updated to include studies from 2013-mid-April 2014. References of relevant 
systematic  reviews  were  also  searched.  Searches  only  captured  articles 
published  in  peer-reviewed  journals.  Combinations  of  the  following  search 
terms were used in full text searches: vaginismus, (superficial) dyspareunia, 
sexual  dysfunction  &  pain,  (provoked,  localised)  vulvodynia,  vestibulodynia, 
vestibulitis, and variations of randomised controlled trial (see Appendix 1 for 
full search strategy). These terms were derived from the inclusion criteria, as 
well  as  previous  systematic  reviews  (Andrews,  2012;  McGuire  &  Hawton, 
2001; Melnik, Hawton & McGuire, 2012). 
 
Inclusion criteria 
Studies were included in the review if the following criteria were met: 20 
 
  Participants were women over 16 years with vaginismus, dyspareunia 
or vulvodynia (all subtypes) 
  Participants were randomised or quasi-randomised 
  Studies had at least one psychological treatment arm compared with a 
control or other treatment arm (psychological or medical) 
  Effectiveness  was  evaluated  using  one  or  more  of  the  following 
outcomes: pain, sexual functioning (behavioural & cognitive measures) 
or related psychological distress (e.g. sexual anxiety). 
 
Exclusion criteria 
Studies were excluded if the following criteria were met. 
  Participants  were  women  with  vaginal  pain  due  to  known  medical 
conditions (e.g. endometriosis, sexually transmitted infections, cancer, 
inflammatory  problems,  dermatoses,  menopause)  or  with  deep 
dyspareunia or chronic pelvic pain (beyond the scope of the current 
review) 
  Studies were published in languages other than English.  
 
Study identification  
A  total  of  1548  studies  were  retrieved  from  initial  electronic  and  reference 
searches after de-duplication (see Figure 1 for study flow). The author and 
another clinical psychologist independently sifted all studies retrieved from the 
electronic  searches.  Any  discrepancies  in  decision  about  inclusion  or 
exclusion of studies were discussed and agreed. 
 
The  1517  studies  that  were  excluded  based  on  titles  and  abstracts  either 
failed  to  meet  the  population  criteria  or  were  non-randomised  designs  or 
reviews. Thirty one studies were read in full and 20 were excluded for the 21 
 
following  reasons:  16  had  no  psychological  treatment  arm  (Bornstein  & 
Abramovici,  1997;  Bornstein,  Livnat,  Stolar  &  Abramovici,  2000;  Bornstein, 
Tuma, Farajun, Azran & Zarfati, 2010; Bornstein, Zarfati, Goldik & Abramovici, 
1995;  Donders  &  Bellen,  2012;  Donders,  Dreher,  Bellen  &  Fiews,  2013; 
Farajun, Zarfati, Abramov, Livoff & Bornstein, 2012; Foster, Dworkin & Wood, 
2005; Foster et al., 2010; Murina, Bianco, Radici, Felice, Di Martino & Nicolini, 
2008; Murina, Graziottin, Felice, Radici & Tognocchi, 2013; Nyirjesy, Sobel, 
Weitz,  Leaman,  Small  &  Gelone  2001;  Petersen,  Giraldi,  Lundvall  & 
Kristensen,  2009)  and/or  were  found  to  be  non-randomised  clinical  trials 
(Fowler,  2000,  McKay,  Kaufman,  Doctor,  Berkova,  Glazer  &  Redko  2001; 
Peters, Carrico & Boura, 2011) and two were unavailable in English (Bazin et 
al.,  2011;  Zukerman,  Roslik  &  Orvieto,  2005).  Two  studies  included 
reproduced data from original studies (Bohm-Starke, Brodda-Jansen, Linder & 
Danielsson, 2007; ter Kuile, van Lankveld, Groot, Melles, Neffs & Zandbergen, 
2007)  and  were  used  to  obtain  additional  information  about  the  relevant 
included  studies,  but  data  were  not  double  counted.  Update  searches 
retrieved 288 studies, of one which met inclusion criteria, giving a total of 12 
included studies. 22 
 
 
Figure 1: Flow chart of included and excluded studies 
   
Data extraction  
The large majority of included studies reported continuous data, from which 
the means, standard deviations and sample sizes were extracted. If the study 
used categorical data, events-based outcomes were extracted. If the required 
data were not included in the published article, authors were contacted. Data 
from three studies were obtained from the authors. One study provided full 
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in full 
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Studies included 
in review 
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Studies 
excluded 
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Studies 
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(n= 20) 
 
Studies 
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databases 
(n= 1917) 
Studies 
retrieved via 
reference 
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Study titles or 
abstracts retrieved 
after de-duplication 
(n= 1548) 
 
 
Study titles and 
abstracts 
checked 
(n= 1548) 
 
Studies included 
from update 
searches 
(n=1) 23 
 
data  after  partially  including  RCT  data  as  part  of  a  regression  model 
(Desrochers,  Bergeron,  Khalifé,  Dupuis  &  Jodoin,  2010).  Two  studies  (van 
Lankveld, Everaerd & Grotjohann, 2001; van Lankveld, ter Kuile, de Groot, 
Melles,  Nefs  &  Zandbergen,  2006)  provided  raw  datasets  from  which  the 
means and standard deviations were calculated. This explains variation in N in 
the analyses, accounted for by missing data. Calculations from van Lankveld 
et al., (2006) were based on single questionnaire items rather than composite 
scores. Data from one study were no longer available (Schnyder, Schnyder-
Lüthi, Ballinari & Blaser 1998), although another meta-analysis reported odds 
ratios  for  this  study  (McGuire  &  Hawton,  2001).  Data  from  Danielsson, 
Torstensson,  Brodda-Jansen  &  Bohm-Starke  (2006)  included  medians  and 
interquartile ranges; therefore, data could not be converted using standardised 
methods (Hozo, Djulbegovic & Hozo, 2005; Deeks, Higgins & Altman, 2008). 
Limited categorical data allowed for the use of odds ratios instead. 
Data analysis   
Using Review Manager 5 software version 5.2 (The Cochrane Collaboration, 
2012),  means  and  standard  deviations  entered  into  random  effects  meta-
analyses  to  calculate  mean  differences  or  standardised  mean  differences. 
Event-based  outcomes  were  entered  into  random  effects  meta-analyses  to 
calculate  odds  ratios.  The  analyses  examined  a  range  of  psychological 
treatments: CBT (individual, group & self-help), behavioural (biofeedback & 
exposure),  hypnotherapy  and  supportive  therapy.  These  were  compared  to 
medical treatments or control conditions: surgery, medication, topical cream or 
waiting list. The main outcomes examined were: pain and sexual functioning.  
 
Effect sizes (Cohen, 1992) from baseline to post-treatment were calculated for 
psychological treatment arms. This enabled comparisons to be made between 24 
 
trials, in particular, to examine differences between vaginal pain defined as 
psychiatric (vaginismus) or medical (vulvodynia).   
 
Quality of studies  
The NICE (2012) methodology checklist for randomised controlled trials was 
used to assess the quality of included studies. The checklist assessed four 
domains: 1) selection bias (randomisation method, allocation concealment & 
comparability  of  groups  at  baseline),  2)  performance  bias  (blinding  & 
equivalent care), 3) attrition bias (drop-out) and 4) detection bias (reliability of 
outcomes). As the studies examined psychological interventions, blinding was 
less  applicable.  However,  studies  that  attempted  to  address  this  by  using 
independent assessors were viewed as superior on that domain to studies that 
did not. The level of risk was rated as 'low, ‘high’ or ‘unclear’ on each domain, 
based on the accumulated risk of the items. Ratings were undertaken by the 
researcher  and  an  independent  assessor.  Disagreements  were  resolved 
through  discussion,  ensuring  that  criteria  were  applied  consistently  across 
studies. Quality of the studies was used to inform the integrity of treatment 
effects. 
 
Researcher allegiance can impact considerably on effects found in controlled 
trails  (Leykin  &  DeRubeis,  2009);  therefore,  this  was  assessed  using  a 
process developed by Gaffan, Tsaousis and Kemp-Wheeler (1995). Studies 
were  assessed  on  several  domains:  citing  previous  research  supporting  a 
particular  treatment;  discussing  the  superiority  of  a  particular  treatment; 
including a description of treatment that exceeds 10 sentences; authorship of 
treatment; and having a sole active treatment condition. Research was rated 
as having ‘strong’, ‘moderate’, ‘weak’ or ‘no’ allegiance.  
 25 
 
All quality criteria can be found in Table 1. 26 
Table 1  
 
Study Characteristics for included studies  
Study ID  Population  Intervention/ 
Comparator 
Outcomes  Selection bias  Performance bias  Attrition bias  Detection bias  Research  
allegiance  
Al-sughayir 
2005 
36 women with 
vaginismus  
(DSM-IV) 
 
Aged 17-40 
(mean age 23) 
 
Outpatient 
psychiatric clinic, 
Saudi Arabia  
 
Mean duration of 
problem 9.52 
months 
1. Hypnotherapy (n=18) 
Once weekly 45-60 
minutes, wife only 
(mean sessions 4.7) 
 
2. Behaviour therapy 
(n=18) 
Once weekly 45-60 
minutes, both wife and 
husband  
(mean sessions=10) 
 
 
Sex related anxiety 
(5 point scale) 
 
Wife’s sexual 
satisfaction (5 point 
scale) 
 
Husband’s sexual 
satisfaction (5 point 
scale) 
Design: quasi-
randomised 
 
Randomisation method: 
alternate allocation  
 
Allocation concealment: 
not reported 
 
No significant 
differences between 
demographic and 
outcome measures at 
baseline  
 
Risk of selection bias: 
high  
Blinding: Independent 
psychology assessment 
pre and post treatment. 
 
No additional treatments 
during study 
 
Treatment administered 
until symptoms reduced 
(considerable variation in 
number of sessions 
offered) 
 
Risk of performance bias: 
high   
Follow-up: none 
 
Dropout: 
Group 1: post-treatment  
2/18  
Group 2: post-treatment  
3/18  
 
Data for 5 dropouts not 
included  
 
No ITT analysis reported 
 
Risk of attrition bias: 
unclear 
Follow-up duration 
inadequate 
 
Basic outcome 
measures not well 
defined; not 
validated  
 
No measure of 
sexual functioning or 
pain 
 
Attempt to blind 
investigators to 
treatment exposure 
 
Risk of detection 
bias: high 
Strong 
allegiance 
to 
hypnother
apy  
Bergeron et 
al. (2001) 
[Bergeron 
Khalifé, 
Glazer & 
Binik (2008) 
[follow-up] 
 
78 women with 
vestibulodynia  
 
 
Mean age 26.8 
 
Canada  
1. Vestibulectomy 
(n=22) 
30 minute operation; 
information given before 
and after surgery by 
gynaecologist  
 
2. Biofeedback (n=28) 
Self-insertion of EMG 
sensor into vagina; 
twelve 45-minutes 
sessions over 8 weeks. 
 
3. Group CBT (n=28) 
Vestibular pain 
index (11-point 
scale) 
 
Pain intensity of 
vaginal intercourse 
(11-point scale) 
 
McGill Pain 
Questionnaire 
(MPQ): 
Pain Rating Index & 
Sensory scale 
 
Design: randomised  
 
Randomisation method: 
blocked  
 
Allocation concealment: 
not reported 
 
No significant 
differences between 
groups on demographic 
or pre-treatment 
outcomes. 
 
Blinding: outcomes 
administered by 
independent clinical 
associate  
 
No additional treatments 
requested during study. 
5/76 at post-treatment and 
17/51 at 2.5 year follow-up 
reported using other 
means of pain relief, This 
did not differ as function of 
treatment. 
 
Follow-up: 6 months  
 
Dropout: 
Group 1: 7/22 pre-
treatment; 3/13 6-month 
follow-up. Significantly 
higher dropout pre-
treatment than in groups 
2 & 3.  
Group 2:1/28 pre-
treatment; 2/27 post-
treatment; 8/25 6-month 
follow-up. Significantly 
more dropouts at follow-
Follow-up duration 
appropriate 
 
Established and 
reliable outcome 
measures used 
 
Attempt to blind 
investigators to 
treatment exposure 
 
Risk of detection 
bias: low 
 
Moderate 
allegiance 
to CBT   27 
Eight 2-hour sessions 
over 12 weeks; led by 
psychologists. 
 
 
Sexual  
Information Scale 
 
Frequency of sexual 
intercourse 
 
Global Severity 
Index of Brief 
Symptom Inventory 
(BSI-GSI) 
 
Credibility  
Participants randomly 
assigned to 1 of 2 
gynaecologists (group 1) 
or 1 of 2 psychologists 
(groups 2 & 3). 
 
Adherence to manual: 
Group 2: 57% 
compliance with 
homework 
Group 3: 0.87 inter-rater 
reliability and 65% 
compliance with 
homework 
 
Risk of selection bias: 
low 
Risk of performance bias: 
unclear 
up. 
Group 3: 1/28 pre-
treatment dropout. 
 
No significant 
differences in 
demographic or pre-
treatment outcomes in 
completers or dropouts 
at 6-month and 2.5 year 
follow-up 
 
2.5 year follow-up 
Group 1: n=15 
Group 2:n=17 
Group 3: n=19 
 
ITT analysis undertaken. 
 
Risk of attrition bias: low 
 
Desrochers 
et al., 2010 
 
 
97 women with 
vestibulodynia 
 
Mean age: 
Group 1: 26  
Group 2: 27  
 
Mean onset of 
problem 5.5 
years 
 
 
1. Group CBT(n=52) 
Ten 90-minute sessions, 
run by trained and 
supervised 
psychotherapists 
 
2. Topical Treatment 
(n=45) 
8 weeks corticosteroid 
cream (1%) applied to 
vestibule twice a day for 
13 weeks, plus lubricant 
during penetration and 
education. Prescribed by 
2 gynaecologists. 
Discontinue after 8 
weeks if no 
improvement.  
Gynaecological 
examination  
  
Pain during 
intercourse (0-10 
visual analogue 
scale) 
 
MPQ-PPI 
 
Frequency of 
intercourse 
 
Female Sexual 
Functioning Index 
(FSFI) 
 
Sexual satisfaction  
Design: randomised  
 
Randomisation method: 
blocked  
 
Allocation concealment: 
not reported 
 
No significant 
differences between 
groups on demographic 
or clinical outcomes, 
apart from pain duration 
(longer in group 2). 
 
Adherence to manual 
checked 
 
Blinding: unknown 
 
Concurrent treatments: 
unknown  
 
Risk of performance bias: 
unclear 
 
 
Follow-up: 6 months 
 
Dropout (based on 
unpublished data) 
Group 1: 13/52 post-
treatment; 4/39 follow-up 
Group 2: 15/45 post-
treatment; 1/30 follow-up 
 
No significant 
differences found 
between dropouts and 
completers on 
demographic or clinical 
variables apart from fear 
of pain (higher in 
dropouts) 
 
Follow-up duration 
appropriate 
 
Established and 
reliable outcome 
measures used 
 
Investigators not 
blind to treatment 
exposure 
 
Risk of detection 
bias: unclear  
Moderate 
allegiance 
to CBT   28 
 
Brief Symptom 
Inventory/Global 
Severity Index 
(BSI-GSI) 
 
Pain catastrophising 
Scale (PCS) 
 
Pain Intercourse 
Self-Efficacy Scale 
 
Risk of selection bias: 
low 
ITT analysis undertaken 
 
Risk of attrition bias: low 
Brown Wan, 
Bachmann & 
Rosen 
(2009) 
53 women with 
vulvodynia 
(generalised and 
provoked) 
 
Non-responders 
from previous 
trial of dietary 
therapy 
 
Mean age 47 
 
1. CBT based self-
management (n=26) 
Twelve 2-hour weekly 
group sessions; 
delivered by nurse 
practitioner, psychologist 
and physiotherapist 
 
2. Amytriptyline (tricyclic 
antidepressant) (n=13) 
10mg a day for 6 weeks, 
increased to 20mg if well 
tolerated, for remainder 
of study 
 
3. Amytriptyline + 
Triamcinolone cream 
(corticosteroid) (n=14) 
10mg a day for 6 weeks, 
increased to 20mg if well 
tolerated for remainder 
of study. Plus once daily 
application of 
triamcinolone  5mg 
cream on affected area 
Cream discontinued at 6 
McGill Pain 
Questionnaire 
(MPQ): Pain Rating 
Index  
Design: randomised 
prospective  
 
Randomisation method: 
computer generated 
 
Allocation concealment: 
envelopes. Twice as 
many participants 
randomised to group 1, 
than groups 2 & 3 
 
No significant 
differences between 
groups on demographic 
or pre-treatment 
outcomes for 
completers. ITT 
revealed significantly 
more pain in group 3 
than group 1 at baseline 
 
Adherence: Group 1 
evaluated by attendance 
(81% attended all) and 
self-reported 
Blinding: neither 
participants nor staff 
blinded to treatment 
 
Discontinued any other 
treatments for pain during 
study 
 
Risk of performance bias: 
unclear 
Follow-up: none  
 
Dropout: 
Group 1: 5/26 post-
treatment  
Group 2: 2/13 post-
treatment 
Group 3: 3/14 post-
treatment 
 
No significant 
differences in refusal or 
dropout rates between 
groups. 
 
ITT analysis undertaken 
for baseline scores only 
 
Risk of attrition bias: low 
Follow-up duration 
inadequate 
 
Established and 
reliable outcome 
measures used 
 
Investigators not 
blind to treatment 
exposure 
 
Risk of detection 
bias: high 
Weak  
allegiance, 
no 
treatment 
notably 
favoured   29 
weeks 
 
compliance.  
Groups 2 & 3 evaluated 
by tablet count and 
cream measurement 
(100% compliance).  
No significant difference 
in adherence between 
groups. 
 
Risk of selection bias: 
low 
Danielsson 
et al., (2006) 
 
46 women with 
vestibulodynia 
 
Mean age: 
Group 1: 25.8 
Group 2: 23.3 
 
Outpatient 
vuvlar clinic, 
Sweden 
1. Lidocaine (local 
anesthetic) (n=23)  
2% gel, 5% ointment; 
applied 5-6 times a day 
for 2-4 months 
 
2. EMG biofeedback (n= 
23) 
Vaginal sensor applied 3 
times a day for 10 
minutes per session at 
home 
Pain pressure 
thresholds 
 
Short form 36 (SF-
36) 
 
Prime Care 
Evaluation of Mental 
Disorders (PRIME 
MD) 
 
Quality of Life 
(QOL) 0-100 visual 
analogue scale 
 
Sexual functioning 
0-100 visual 
analogue scale 
 
Coital pain 0-100 
visual analogue 
scale 
Design: randomised  
 
Randomisation method: 
computer generated 
 
Allocation concealment: 
not reported 
 
Group differences at 
baseline not adequately 
reported 
 
Adherence: 
Group 1: 95% 5 times 
per day; 50% used 
ointment only after 2 
months 
Group 2: 0% 3 times per 
day; 56% 2 times per 
day. 
 
Risk of selection bias: 
unclear 
Blinding: not reported 
 
Concurrent treatments: 
unknown  
 
Risk of performance bias: 
unclear 
Follow-up: 6 and 12 
months 
 
Dropout: 
Group 1: 4/23 post-
treatment; 4/19 12 
month follow-up 
Group 2: 5/23 post-
treatment; 1/18 12 
month follow-up 
 
No ITT analysis reported 
 
Risk of attrition bias: 
unclear 
Follow-up duration 
adequate 
 
Established and 
reliable outcome 
measures 
 
Investigators not 
blind to treatment 
exposure 
 
Risk of detection 
bias: unclear 
Weak  
allegiance, 
neither 
treatment 
notably 
favoured   
Masheb, 
Kerns, 
Lozano, 
Minkin & 
50 women with 
vulvodynia  
(generalised & 
provoked) 
1. CBT (n=25) 
Ten weekly 60 minute 
sessions 
 
Physician 
assessment: 
speculum, cotton 
swab and erythema.  
Design: randomised  
 
Randomisation method: 
computer generated 
Blinding: treatment blinded 
to gynaecologists 
undertaking examinations. 
Participants and 
Follow-up: 6 and 12 
months 
 
Dropout: 
Follow-up duration 
adequate 
 
Established and 
Strong 
allegiance 
to CBT 30 
Richman 
(2009) 
 
 
   
Mean age 43 
 
University 
students  
 
 
 
2. Supportive 
Psychotherapy (n=25) 
Ten weekly 60 minute 
sessions 
 
Both treatments 
delivered by doctoral 
level research therapists  
 
 
 
Multidimensional 
Pain Inventory (MPI) 
 
McGill Pain 
Questionnaire 
(MPQ) 
 
Female Sexual 
Functioning Index 
(FSFI) 
 
Beck Depression 
Inventory (BDI) 
 
Pain Anxiety 
Symptom Scale 
(PASS) 
 
Global improvement 
rating (scale 0-5) 
 
Satisfaction and 
credibility rating 
(scale 0-10) 
 
Allocation concealment: 
not reported. Group 
assignment revealed 
post-assessment. 
 
Adherence to manuals 
checked by supervisors.  
 
No significant 
differences between 
groups on demographic, 
psychiatric or pain 
history outcomes. 
 
Risk of selection bias: 
low 
researchers not blind to 
treatment. 
 
Concurrent treatments: 
participants excluded if 
started psychotherapy, 
psychopharmalogical or 
pain treatment in past 
month 
 
Risk of performance bias: 
unclear  
Group1:  2/25 post-
treatment; 1/23 at 6 and 
12 month follow-up  
Group 2: no drop-out 
 
No ITT analysis reported 
 
Risk of attrition bias: 
unclear 
reliable outcome 
measures 
 
Attempt to blind 
investigators to 
treatment exposure 
 
Risk of detection 
bias: low   
Schnyder et 
al., (1998) 
 
 
44 women with 
vaginismus 
(DSM-III; 
acquired & 
lifelong) 
 
Mean age 28 
 
Mean duration of 
problem 4.02 
years 
 
Outpatient 
1. In vivo desensitisation 
(n=21) 
Dilators introduced 
manually by physician  
 
2. In vitro desensitisation 
(n=23) 
Dilators introduced 
verbally by physician 
 
Both groups 10-15 
minutes of 
desensitisation 5 times a 
Successful 
intercourse 
(outcome measure 
not described in 
detail) 
Design: quasi-
randomised  
 
Randomisation method: 
alternate allocation. Two 
participants requested 
not to be in group1 and 
were put in group 2 
 
Allocation concealment: 
not reported 
 
No significant 
Blinding: not reported  
 
Concurrent treatments: 
unknown  
 
Risk of performance bias: 
unclear 
Follow-up: 10 months 
 
Dropout: 
8/44 at follow-up 
 
Dropout differences by 
group not reported  
 
No ITT analysis reported 
 
Risk of attrition bias: 
high 
Follow-up duration 
adequate 
 
Unknown whether 
outcome measure is 
reliable 
 
Investigators not 
blind to treatment 
exposure 
 
Risk of detection 
bias: high  
Moderate 
allegiance 
to 
behaviour
al 
treatment 31 
obstetrics and 
gynaecology 
department, 
Switzerland  
week. Therapy sessions 
every 2 weeks 
 
Number of sessions not 
reported  
 
Therapy sessions  
Treatment delivered by 
two experienced sex 
therapists  
differences between 
groups on demographic 
variables or problem 
severity. Significantly 
more patients in group 2 
found it difficult to talk 
about sex and held 
negative attitudes about 
their bodies.  
 
Risk of selection bias: 
high 
 
Ter Kuile, 
Melles, de 
Groot, 
Tuijnma-
Raasvel & 
van 
Lankveld 
(2013) 
70 women with 
vaginismus 
(lifelong) and 
their partners 
 
Mean age 28.9 
 
Mean duration of 
problem  
10.41 years 
 
Outpatient Clinic 
Psychosomatic 
Gynecology and 
Sexology, 
Netherlands 
 
1. Exposure Therapy 
(n=35) 
Maximum of three 
2-hr sessions within 1 
week, plus two follow-up 
sessions over 5 weeks. 
In vivo desensitation, 
self-controlled; verbally 
directed by therapist.  
Treatment delivered by 
4 female psychologists 
and one experienced 
social worker 
 
2. Waiting list (n=35) 
Successful 
intercourse (as 
recorded in a diary) 
 
Golombok Rust 
Inventory of Sexual 
Satisfaction (GRISS) 
 
Fear of Sexuality 
Questionnaire (FSQ) 
 
Female 
Sexual Distress 
Scale (FSDS) 
Design: Randomised 
 
Randomisation method: 
blocked and stratified  
 
Allocation concealment: 
Yes 
 
No significant 
differences between 
groups on demographic 
variables or sexual 
dysfunctions. However 
control group  
significantly higher 
baseline sexual distress 
scores 
(FSDS)  
 
Risk of selection bias: 
unclear 
Blinding: not reported  
 
Concurrent treatments: 
unknown  
 
Risk of performance bias: 
high 
Follow-up: 6 and 12 
weeks 
 
Dropout: 
Group 1: 2/35 post-
treatment, 2/33 follow up 
Group 2: 3/35 post-
treatment 
 
ITT analysis undertaken 
 
Risk of attrition bias: low 
Follow-up duration 
brief 
 
Established and 
reliable outcome 
measures 
 
Investigators not 
blind to treatment 
exposure 
 
Risk of detection 
bias: unclear 
Strong 
allegiance 
to CBT 
van 
Lankveld et 
al., (2001) 
55 women 
(vaginismus 
n=28; 
dyspareunia 
n=25) 
 
1. CBT bibliotherapy 
(n=125) 
Given manual to read; 
10 weeks duration with 
telephone support  
 
Golombok Rust 
Inventory of Sexual 
Satisfaction (GRISS) 
 
Maudsley Marital 
Questionnaire 
Design: randomised 
(partially) 
 
Randomisation method: 
blocked card draw. 
21/125 couples in 
Blinding: assessed by 
psychologist not involved 
in treatment. 
 
Concurrent treatments: 
unknown  
Follow-up: 10 weeks 
 
Overall dropout: 
Group 1: 14/125 post-
treatment; 11/111 follow-
up 
Follow-up duration 
brief 
 
Established and 
reliable outcome 
measures 
Strong 
allegiance 
to CBT 32 
Subset of 
couples with 
numerous 
sexual 
dysfunctions 
 
Mean age of 
subsets 
unknown, overall 
mean age of 
females 35  
 
Outpatient 
gynaecology 
and sex clinic, 
Netherlands  
Group 1 broken down 
further into: randomised 
participants (n=104) 
(self-initiated contacts if 
having difficulties); and 
non-randomised 
participants (n=21) 
(scheduled telephone 
contacts) 
 
2. Waiting list (n=98) 
 
 
 
(MMQ) 
 
Intimate Contact 
Body Scales 
 
Self-rated evaluation 
of treatment (4 item 
scale) 
 
Compliance  
treatment condition were 
not randomised 
 
Allocation concealment: 
unclear 
 
No significant 
differences between 
groups on demographic 
variables or sexual 
dysfunctions. 
 
Risk of selection bias: 
high 
 
Risk of performance bias: 
unclear  
Group 2: 10/98 post-
treatment-up; 3/88 
follow-up 
 
Subgroup dropout: 
None 
 
Attrition rates not 
compared 
 
ITT analysis undertaken 
 
Risk of attrition bias: low 
 
Attempt to blind 
investigators to 
treatment exposure 
 
Risk of detection 
bias: unclear 
van 
Lankveld et 
al., (2006) 
 
117 couples 
(women with 
vaginismus, 
DSM-IV-TR, 
lifelong only) 
 
Mean age 
females 28.6 
 
Mean age 
partners 31 
 
Mean duration of 
problem 11 
years 
 
Outpatient 
sexology clinic, 
Netherlands 
 
 
1. Group CBT (n=43) 
CBT manual and CD-
ROM, plus ten 2-hour 
group sessions (female 
partner only) 
 
2. Bibliotherapy CBT 
(n=38) 
CBT manual and CD-
ROM, plus six biweekly 
15-minute telephone 
calls 
 
3. Waitlist control (n=36)  
12 weeks on waiting list 
 
3 months treatment 
duration 
 
Treatment delivered by 
10 therapists (7 senior, 3 
junior) 
Primary Endpoint 
Questionnaire 
(levels of 
penetration 
achieved) 
 
Mini International 
Neuropsychiatric 
Interview (MINI) 
 
Female Sexual 
Function Index 
(FSFI) 
 
Maudsley Marital 
Questionnaire 
(MMQ) 
 
Golombok Rust 
Inventory of Sexual 
Satisfaction (GRISS) 
 
Design: randomised  
 
Randomisation method: 
urn allocation, by 
someone not involved in 
assessment or 
treatment.  
 
Allocation concealment: 
not reported 
 
No significant 
differences between 
groups on 
demographics, 
treatment history or 
sexual functioning 
 
Risk of selection bias: 
low 
Blinding: 3/4 assessors 
blinded to treatment;1/4 
assessor involved in 
treatment delivery and 
data collection  
Physical examiners 
blinded to treatment  
 
Concurrent treatments: 
unknown  
 
Risk of performance bias: 
unclear 
Follow-up: 3 and 12 
months  
 
Dropout: 
24/117 couples post-
treatment. Significantly 
fewer dropouts in group 
3 (3/36) than group 1 
(11/43) & 2 (10/38).  
At 3 months follow-up, 
1/33 couples in group 1 
and 3/27 in group 2 
dropped out.   
 
No significant 
differences found on 
demographic or sexual 
functioning between 
dropouts and 
completers.  
 
ITT analysis undertaken 
Follow-up duration 
adequate 
 
Established and 
reliable outcome 
measures 
Attempt to partially 
blind investigators to 
treatment exposure 
 
Risk of detection 
bias: unclear 
Strong 
allegiance 
to CBT 33 
  Sexual and Physical 
Abuse 
Questionnaire 
(SPAQ) 
(last score carried 
forward) 
 
Risk of attrition bias: low 
Weijmar-
Schultz et 
al., (1996) 
14 women with 
vestibulodynia 
and unable to 
have intercourse 
 
Mean age 24 
 
Dutch 
gynaecology 
department  
 
 
1. Behavioural therapy + 
placebo surgery (n=7) 
Hospitalised for one 
night and given local 
anaesthetic 
 
2. Surgery + behavioural 
therapy (n=7) 
Hospitalised for one 
night and surgical 
excision under local 
anaesthetic performed  
  
Participants excluded if 
initiated other pain 
treatment in the past 2 
months 
Problem severity (5-
point scale) 
 
 
Design: randomised  
 
Randomisation method: 
not reported  
 
Allocation concealment: 
not reported 
 
Comparability of groups 
at baseline not reported 
 
Risk of selection bias: 
high 
Blinding: participants were 
blinded 
 
Comparability of care 
during study duration 
unclear. All participants 
hospitalised to make 
groups as equal as 
possible.  
 
Risk of performance bias: 
low 
Follow-up: none, but 
post-treatment scores 
collected on average 3 
years after treatment 
 
Wide-ranging times for 
post-treatment outcome 
(8-56 months) 
 
Substantial differences 
in treatment duration 
Group 1: 17 months 
Group 2: 11 months 
 
No ITT analysis  
 
No evaluation of sexual 
functioning 
 
Risk of attrition bias: 
high 
Follow-up duration 
unclear 
 
Basic outcome 
measure; unknown 
whether outcome is 
reliable 
 
Risk of detection 
bias: high 
Weak 
allegiance, 
neither 
treatment 
notably 
favoured     
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RESULTS 
Included studies  
Of the 12 studies included in the review, ten provided post-treatment data for a total 
number of 417 participants. Four studies provided follow-up data with a maximum 
number of 180 participants. One was a follow-up study for which data are presented 
together  with  the  original  study  (Bergeron  et  al.,  2001).  Five  studies  examined 
vaginismus; five examined vestibulodynia; and two examined a mix of provoked and 
generalised vulvodynia. One study had three active treatment arms, one study had 
two  active  treatment  arms  and  one  control  arm,  seven  studies  had  two  active 
treatment arms, and two studies had one active treatment arm and one control arm. 
In  terms  of  psychological  treatment,  six  studies  evaluated  CBT,  six  evaluated 
behavioural  therapy,  one  evaluated  hypnotherapy  and  one  supportive  therapy. 
When entering these into the meta-analysis, CBT and behavioural treatments were 
most  frequently  selected  as  the  active  treatment  when  compared  with  other 
psychological  treatments.  Of  the  active  comparisons,  five  studies  compared 
psychological treatment with another psychological treatment, two with surgery, and 
three with medication. Three compared psychological treatments with a waiting list 
control. The mean age across studies was 30 years.  
 
Risk of bias  
All studies included in the review were evaluated for risk in terms of selection bias, 
performance  bias,  attrition  and  detection  bias  (see  Table  1).  Selection  bias  was 
rated  as  high  in  four  studies,  unclear  in  two  studies  and  low  in  five  studies. 
Performance bias was rated as high in two studies, unclear in eight studies and low 
in one study. Attrition bias was rated as high in two studies, unclear in three studies 
and low in six studies. Detection bias was rated as high in four studies and unclear 
in five studies and low in two studies. Overall, most studies were rated as unclear 
due to a lack of reported information or an inability to adequately blind psychological 35 
treatment. Research allegiance was also evaluated for all studies. This was rated as 
weak in three studies, moderate in three studies and strong in five studies.   
 
Treatment effects from the meta-analysis  
Combining  multiple  studies into  one analysis  will  inevitably  result in a  degree  of 
heterogeneity. Heterogeneity is the level of variation among studies and represents 
both clinical variation, such as the population or intervention, and methodological 
variation,  such  as  the  study  design.  Heterogeneity  was  calculated  using  the  I² 
statistic. In line with similar reviews, thresholds used for heterogeneity levels were: 
<25% low, 25-50% moderate, and >50% high. All results can be found in [Table 2]. 
 
Forest plots (Appendix 2) compare two treatment groups on one outcome at a time. 
The means, standard deviations and number of participants from each study arm 
are used to calculate a mean effect. The mean effect is represented by a diamond, 
which can be seen to favour one treatment over another depending on where it falls 
along the y-axis. If the diamond touches the x-axis, the difference between groups is 
not significant (indicated by the p value).  36 
Table 2 
Comparisons of psychological treatment with other treatments or controls 
Study ID  N  Populations   Treatment  Comparator  Outcome  Z 
 
P  Heterogeneity  
Bergeron et al., (2001) 
Desrochers et al., (2010) 
Brown et al., (2009) 
143  Vestibulodynia  
Provoked/generalised 
vulvodynia 
CBT  Medical (surgery, topical 
cream & medication) 
General pain (not limited 
to intercourse) post-
treatment 
1.40  0.16  Moderate (25%) 
Bergeron et al., (2001) 
Desrochers et al., 2010 
 
111  Vestibulodynia  CBT  Medical (surgery & topical 
cream) 
Pain on intercourse post-
treatment 
Pain on intercourse 
follow-up 
0.77 
 
0.07 
0.44 
 
0.10 
High (77%) 
 
Moderate (45%) 
Bergeron et al., (2001) 
Desrochers et al., (2010) 
 
111  Vestibulodynia  CBT  Medical (surgery & topical 
cream) 
Sexual functioning post-
treatment 
Sexual functioning follow-
up 
0.21 
 
0.79 
0.83 
 
0.43 
None 
 
None 
Danielsson et al., (2006) 
Weijmar-Schultz et al., (1996) 
46  Vestibulodynia 
 
Behaviour Therapy  Medical (medication & 
surgery) 
Symptom elimination 
(follow-up) 
0.41  0.68  None 
Bergeron et al., (2001) 
Masheb et al., (2009) 
van Lankveld et al., (2006) 
148  Vestibulodynia  
Provoked/generalised 
vulvodynia 
Vagnismus 
CBT  Other psychological 
(biofeedback, supportive 
& bibliotherapy) 
Pain on intercourse post-
treatment 
 
0.32  0.75  Low (15%) 
Bergeron et al., (2001) 
Masheb et al., (2009) 
83  Vestibulodynia  
Provoked/generalised 
vulvodynia 
CBT  Other psychological 
(biofeedback & 
supportive) 
Pain on intercourse 
follow-up 
1.08  0.28  High (69%) 
Bergeron et al., (2001) 
Masheb et al., (2009) 
83  Vestibulodynia  
Provoked/generalised 
vulvodynia 
CBT  Other psychological 
(biofeedback & 
supportive) 
 
Sexual functioning post-
treatment 
1.03  0.30  None 
Al-sughayir (2005) 
Masheb et al., (2009) 
van Lankveld et al., (2006) 
134  Vaginismus  
Provoked/generalised 
vulvodynia 
Cognitive & behaviour 
therapies 
Other psychological 
(hypnotherapy, supportive 
& bibliotherapy) 
Sexual anxiety post-
treatment 
1.60  0.11  Low (23%) 
van Lankveld et al., (2001) 
van Lankveld et al., (2006) 
88  Vaginismus 
Dyspareunia 
Bibliotherapy  Waitlist control  Frequency of sex  2.00  0.05*  None  
van Lankveld et al., (2006) 
ter Kuile et al., (2013) 
66  Vaginismus 
 
Cognitive & behaviour 
therapies 
Waitlist control  Pain on intercourse post-
treatment 
0.89  0.37  High 91% 
van Lankveld et al., (2006) 
ter Kuile et al., (2013) 
66  Vaginismus 
 
Cognitive & behaviour 
therapies 
Waitlist control  Fear of intercourse post-
treatment 
0.28  0.78  High 88% 37 
Psychological versus medical treatment 
Three studies (n=143) of good quality compared post-treatment effects of CBT with 
medical  treatment  on  outcomes  of  general  pain  (not  limited  to  intercourse).  No 
significant  difference  between  groups  was  found.  Two  studies  compared  post-
treatment effects of CBT with medical treatment on outcomes of pain on intercourse. 
No significant difference was found. At 6 months follow-up, no significant effect was 
detected (Appendix 2, Analyses 1.1-1.3).  
 
Two  studies  compared  post-treatment  effects  of  CBT  with  medical  treatment  on 
outcomes  of  sexual  functioning.  No  significant  difference  between  groups  was 
found.  At  6  months  follow-up,  no  significant  effect  was  detected  (Appendix  2, 
analysis 1.4 & 1.5). 
 
Two studies (n=46) of unclear and low quality compared post-treatment odds ratios 
of behaviour therapy versus medical treatment on outcomes of symptom elimination 
(absence of related symptoms). No significant difference was found. See Appendix 
2, analysis 2.1 for forest plot.  
 
Overall, when comparing psychological treatment to active medical treatments on a 
range  of  outcomes,  no  significant  effects  were  found.  This  suggests  that 
psychological  and  medical  treatments  were  equal  in  their  effectiveness;  pre-post 
change (discussed later) suggested that overall, psychological interventions led to 
improvements,  with  effect  sizes  ranging  from  small  to  large  on  pain  and  sexual 
functioning.  
 
CBT versus other psychological interventions 
Three studies (n=148) of good quality compared post-treatment effects of CBT with 
other  psychological  interventions  (biofeedback,  supportive  &  bibliotherapy)  on 38 
outcomes  of  pain  on  intercourse.  No  significant  difference  between  groups  was 
found. Two of these studies compared effects at follow-up (1 & 2.5 years) and no 
significant effect was found (See Appendix 2, analysis 3.1 & 3.2). Observationally, 
vestibulodynia  seemed  to  benefit  more from  other  psychological  treatments  than 
from CBT, whereas for vaginismus, no difference was apparent. However, a non-
significant difference remained even if the vaginismus study was removed (p=0.20). 
 
Two  studies  (n=83)  compared  post-treatment  effects  of  CBT  with  other 
psychological  interventions  (biofeedback  &  supportive)  on  outcomes  of  sexual 
functioning.  No  significant  difference  between  groups  was  found  (Appendix  2, 
analysis 3.3). Data from  Schnyder et  al., (1998)  could not be obtained from the 
original publication; however, a previous meta-analysis (McGuire & Hawton, 2001) 
calculated  odds  ratios  for  this  study  that  compared  two  forms  of  behavioural 
treatment, and found no significant difference on outcomes of successful penetration 
(Z=0.52, p=0.60). 
 
Three studies (n=142) of mixed quality compared post-treatment effects of cognitive 
or behavioural therapy with other psychological therapies (hypnotherapy, supportive 
& bibliotherapy) on outcomes of sexual anxiety. No significant difference between 
groups was found. The study on vestibulodynia (Masheb et al., 2009) did not seem 
to favour  either treatment,  whereas,  the two  studies  on  vaginismus  appeared  to 
favour  CBT.  When  the  vestibulodynia  study  was  removed,  the  effect  became 
significant  (Z=1.94,  P=0.05,  ES=0.47,  CI=-0.00-0.95),  although  one  of  the 
vaginismus studies was rated as high risk on three domains of bias (Appendix 2, 
analysis 3.4). 
 
On  the  whole,  when  comparing  psychological  treatment  to  other  active 
psychological treatments on a range of outcomes, no significant differences were 39 
found, suggesting that psychological treatments were equally in their effectiveness; 
pre-post change (discussed later) suggested that most psychological interventions 
improved pain on intercourse and sexual functioning, with effect sizes ranging from 
small to large. Biofeedback however had no effect on pre-post change on outcomes 
of sexual function or activity. 
 
Psychological treatment versus waitlist control  
Two  vaginismus  studies  (n=88)  of  adequate  quality  compared  effects  of 
bibliotherapy  with  waitlist  control  on  outcomes  of  frequency  of  sex.  A  significant 
effect  was  found  (Z=2.00,  P=0.05,  ES=0.43,  CI=0.86-0.01),  suggesting  that 
psychological treatment is better than no treatment (Appendix 2, analysis 4.1 for 
forest plot).  
 
Two vaginismus studies (n=66) compared effects of CBT and exposure treatment 
with  waitlist  control  on  outcomes  of  pain  and  fear  of  intercourse.  No  significant 
difference was found on either outcome (see analyses Appendix 2, analyses 4.2 & 
4.3). 
 
Effect sizes  
Baseline to post-treatment effects were calculated for psychological treatment arms. 
Thresholds for size of effect were: >0.1 (small); >0.3 (moderate) and >0.5 (large) 
(Cohen,  1992).  Effects  were  considered  in  terms  of  aetiology:  medically  defined 
versus psychiatrically defined conditions. Effects could not be calculated for three 
studies where the required data were not included in the studies (Al-sughayir, 2005; 
Weijmar-Schultz et al., 1998; Danielsson et al., 2006) or where pre-treatment data 
were not included for all outcomes. Effect sizes can be found in Table 3. 
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Effect sizes for medically defined pain 
Four  studies  examined  the  impact  of  psychological  treatment  on  general  pain. 
Effects of CBT ranged from small to large. The effect of biofeedback was  small 
ES=0.16 (Bergeron et al., 2001) and supportive therapy large ES=0.64 (Masheb et 
al., 2009). 
 
Three  studies  examined  the  impact  of  psychological  treatment  on  pain  on 
intercourse. Effects of CBT were large, ES=0.61 (Bergeron et al., 2001), ES=0.69 
(Desrochers et al., 2010), ES=0.53 (Masheb et al., 2009). The effect of biofeedback 
was  also  large  ES=0.71  (Bergeron  et  al.,  2001).  Supportive  therapy  produced a 
moderate effect ES=0.48 (Masheb et al., 2009). The same studies also examined 
the impact of psychological treatment on sexual functioning. Effects of CBT ranged 
from small ES=0.16 (Bergeron et al., 2001) to large ES=0.69 (Masheb et al., 2009). 
A small effect was found for supportive therapy ES=0.15 (Masheb et al., 2009). No 
effect was found for biofeedback.  
 
Two studies examined the impact of psychological treatment on the frequency of 
sexual activity. A very small effect was found in one study ES=0.12 (Bergeron et al., 
2001). No effect of CBT or biofeedback was found. 
 
Effect sizes for psychiatrically defined pain 
Two studies examined the impact of psychological treatment on pain on intercourse 
found  a  large  effects  for  CBT  ES=0.69,  exposure  ES=2.29  and  bibliotherapy 
ES=0.64.  Van  Lankveld  et  al.,  (2006)  also  evaluated  the  ability  to  undertake 
penetrative  behaviours  (excluding  sex)  and  found  a  large  effect  size  for  CBT 
ES=1.19 and bibliotherapy, ES=0.93 (van Lankveld et al., 2006).  
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One study that examined the impact of bibliotherapy on sexual functioning found a 
moderate effect for a dyspareunia subset ES=0.31, and large effect for a vaginismus 
subset ES=1.46 (van Lankveld et al., 2001). This study also examined the impact of 
bibliotherapy  on  the  frequency  of  sexual  activity  and  found  no  effect  for  the 
dyspareunia subset, but in the vaginismus subset, a large effect size was found 
ES=0.49 (van Lankveld et al., 2001).  
 
Table 3 
 
Effect sizes for psychological treatment arms 
Study ID  Populations   Outcome  Treatment  Effect size* 
 
Bergeron et al., (2001) 
 
Brown et al., (2009) 
Desrochers et al. (2010) 
Masheb et al., (2009) 
 
Vestibulodynia  
Provoked/ 
generalised 
vulvodynia 
 
General pain   CBT 
Biofeedback  
CBT 
CBT 
CBT 
Supportive  
0.09  
0.16  
0.31  
0.44  
0.78  
0.64  
Bergeron et al., (2001) 
 
Desrochers et al., (2010) 
Masheb et al., (2009) 
Vestibulodynia  
Provoked/ 
generalised 
vulvodynia 
 
Pain on intercourse  
 
 
CBT 
Biofeedback  
CBT 
CBT 
Supportive 
0.61  
0.71 
0.69  
0.53 
0.48 
Bergeron et al., (2001) 
 
Desrochers et al., 2010 
Masheb et al., (2009) 
Vestibulodynia  
Provoked/ 
generalised 
vulvodynia 
 
Sexual functioning  
 
CBT 
Biofeedback 
CBT 
CBT 
Supportive 
0.16  
No effect 
0.44  
0.69  
0.15 
Bergeron et al., (2001) 
 
Desrochers et al., 2010 
Vestibulodynia  
 
Sexual activity 
frequency 
 
CBT 
Biofeedback 
CBT 
0.12  
<0.1 
<0.1 
van Lankveld et al., (2006) 
 
ter Kuile et al., (2013) 
Vagnismus  Pain on intercourse  Bibliotherapy 
CBT 
Exposure 
0.64 
0.69  
2.29 
ter Kuile et al., (2013)  Vagnismus  Fear of intercourse  Exposure  0.89 
van Lankveld et al. (2006)  Vagnismus  Other penetration 
behaviours 
Bibliotherapy 
CBT 
0.93  
1.19 
van Lankveld et al. (2001) 
 
ter Kuile et al., (2013) 
Dyspareunia  
Vaginismus  
Sexual functioning  Bibliotherapy 
Bibliotherapy 
Exposure 
0.31 
1.46 
<0.1  
van Lankveld et al. (2001)  Dyspareunia  
Vaginismus  
Sexual activity 
frequency 
Bibliotherapy 
Bibliotherapy 
<0.1 
0.49 
*Bold indicates a large effect size 
Summary of effect sizes 
Psychological  treatments  for  vulvodynia  produced  wide-ranging  effect  sizes  for 
general pain; but, when focusing on sexual pain specifically, effect sizes were larger. 
Two  vaginismus  studies  that  examined  pain  found  large  treatment  effects.  This 42 
could  indicate  that  psychological  interventions  have  an  impact  on  sexual  pain 
regardless of assumed aetiology.  
 
In terms of general sexual function, CBT for vulvodynia produced a range of effect 
sizes, from small to large; however, this was not true for the frequency of sexual 
activity. For vaginismus, large effects were found for sexual function and frequency. 
Interestingly, within one study, a large effect was found for sexual frequency in a 
vaginismus subset, but no effect was found in the dyspareunia subset (van Lankveld 
et al., 2001). This could indicate a differential effect of treatment on the two sexual 
dysfunctions.  This  study  was  rated  as  having  a  high  risk  of  selection  bias  and 
analyses were undertaken on a small subset of a wider population,  which could 
impact on the reliability of findings. 
 
DISCUSSION 
A  systematic  review  and  meta-analysis  on  the  effectiveness  of  psychological 
interventions for medically and psychiatrically defined vaginal pain was undertaken. 
Twelve studies were included that compared psychological treatments with medical 
treatments, other psychological treatments and control groups. Outcomes of pain 
and sexual function were examined.  
 
Summary of primary findings 
The primary aim of the review was to examine the effectiveness of psychological 
treatment for an inclusive group of vaginal pain conditions. Overall, no significant 
differences  were  found  between  psychological  and  medical  treatments  on  all 
outcomes, nor were significant differences found between two active psychological 
treatments. This suggests equality in treatment effectiveness. A significant effect of 
psychological  treatment  (bibliotherapy)  for  vaginismus  was  found  only  when 43 
compared with a waitlist control group. The included studies varied in terms on their 
quality. Many studies were rated as having an unclear risk of bias due to information 
not being reported. Two studies included in the meta-analysis stood out as being 
particularly at risk of bias (Alsughayir, 2005 & Weijmar-schultz et al., 1996). These 
studies were included in only one analysis each.  
No studies on psychiatrically defined vaginal pain were found to compare 
psychological with medical treatment. This could be due to the psychiatric definitions 
which might have steered research away from medical comparators. No trials on 
medically defined vaginal pain were found to compare psychological treatment with 
a control group. This could be due to ethical concerns about withholding treatment 
for  pain.  These  gaps  in  the  research  literature  limited  evaluation  of  combined 
effectiveness of treatment of vaginal pain types. 
 
Explanations of primary findings 
The finding that psychological and medical treatment for vulvodynia pain may be of 
equal  effectiveness  is  interesting,  because  medical  treatment  is  often  a  first-line 
option (Updike & Wiesenfeld, 2005; Mandal et al., 2010). This raises a question; 
what  elements  of  pain  are  such  disparate  treatments  acting  on?  Medical 
interventions  (including  medication  &  surgery)  could  be  influencing  physiological, 
bottom-up  aspects  of  pain  by  acting  on  the  peripheral  pain  system,  reducing 
sensitivity or removing nerve endings; whereas psychological treatments could be 
mediating pain and sensitivity via top-down processes, such as emotional, cognitive 
or behavioural aspects of pain. It is unlikely that such a polarised explanation is 
valid.  A  biopsychological  model  would  propose  that  both  psychological  and 
biological processes are influencing pain in a reciprocal way (Melzack & Wall, 1965). 
Only one trial in this review combined psychological and medical placebo, so it is 
difficult to evaluate interactions between psychological and biological processes on 
functioning. Weijmar-Schultz et al., (1996) created a placebo surgery condition by 44 
fabricating an operation, and compared it with a real vestibulectomy in the active 
arm. Both groups also received behaviour therapy which could have confounded 
placebo  effects;  however,  no  differences  were  found  on  symptom  reduction  or 
elimination  between  the  two  treatment  arms.  With  a  total  sample  size  of  14, 
generalisation from this study is limited. In addition, this study was rated as high risk 
on three domains of quality. Nevertheless, the combined treatment design is useful. 
Other  research  has  explored  the  utility  of  multicomponent  treatment  models  for 
vestibulodynia (Backman, Widenbrant, Bohm-Starke & Dahlöf, 2008), but evidence 
on a larger scale is needed to provide informative results about the contribution of 
medical  versus  psychological  input.  Vaginismus  trials  did  not  include  any 
comparisons  with  medical  treatment.  This  prevented  direct  comparisons  with 
vulvodynia, so conclusions about the relative effectiveness of medical treatment for 
vaginismus could not be drawn. 
 
The finding that psychological treatments were equally effective for both medically 
and  psychiatrically  defined  vaginal  pain  makes  it  difficult  to  identify  an  active 
component  of  treatment.  As  discussed,  pain  is  viewed  as  a  multidimensional 
problem; therefore different psychological approaches could be acting on different 
aspects of the pain. For example, supportive therapy may help address emotional 
distress; CBT may help to address unhelpful cognitions; and behavioural therapy 
may help with avoidance behaviour, all of which are top-down processes that can 
influence pain.  Similar  treatment effects were also found on outcomes of sexual 
function. Such equivalence is reminiscent of the much debated dodo verdict that 
suggests  all  credible  psychological  therapies  have  equal  effectiveness  due  to 
common therapeutic factors, rather than to therapeutic methods specific to therapy 
type  (Wampold,  Minami,  Baskin  &  Callen  Tierney,  2002).  However,  this  has  not 
been demonstrated when comparing psychological treatments for physical health 
conditions.  One  might  argue  that  common  therapeutic  factors  found  in  medical 45 
settings  would  be  quite  different  to those found  in  purely  psychological  settings. 
Without a control group it is difficult to determine whether treatments are equally 
effective  or  ineffective.  Two  trials  that  used  control  conditions  demonstrated  a 
significant  effect  in  the  meta-analysis  (van  Lankveld  et  al,  2001  &  2006).  This 
implied that psychological treatment is better than no treatment for vaginismus, but 
this cannot be generalised to vulvodynia.  
 
Due to the variability in treatments and outcomes in the included studies, only two 
analyses included populations of both medically defined and psychiatrically defined 
disorders.  There  was  an  indication  of  a  differential  response  to  treatment  when 
observing  these  analyses,  in  which  vaginismus  appeared  to  benefit  more  from 
cognitive and behavioural therapies than vestibulodynia, when compared with other 
psychological interventions on outcomes of sexual anxiety. This supports the idea of 
vaginismus as an anxiety-driven disorder as opposed to pain-driven disorder. This 
observation is limited to three studies, one of which had a high risk of bias. With a 
greater number of studies, a differential effect could be verified or disputed more 
robustly. Without such data, it is difficult to hypothesise an explanation.  
  
Summary of secondary findings 
The  secondary  aim  of  this  review  was  to  examine  differences  in  effectiveness 
between  vaginal  pain  types.  Individual  baseline  to  post-treatment  effects  were 
calculated for  each  psychological  treatment  arm  to  allow  for  direct  comparisons. 
Two vaginismus studies found large effects for psychological treatment on outcomes 
of sexual pain (van Lankveld et al., 2006; ter Kuile, Melles, de Groot, Tuijnman-
Raasveld & van Lankveld, 2013); these were comparable to and greater than effect 
sizes found for vulvodynia. Similarly, large effect sizes were found for both medically 
and  psychiatrically  defined  vaginal  pain  on  outcomes  of  sexual  functioning.  This 
might  suggest  that  pain  reduction  and  sexual  function  can  be  improved  with 46 
psychological  treatment  regardless  of  the  perceived  aetiology.  A  difference  was 
found between vaginal pain types when examining sexual frequency. Effects in a 
vaginismus  population  were  large,  but  small  or  no  effects  were  found  for  the 
medically  defined  conditions.  This  was  also  evidenced  within  one  trial  with  two 
population subsets; a large effect on bibliotherapy for sexual frequency was found 
for vaginismus, but no effect was found for dyspareunia (van Lankveld et al., 2001). 
This could indicate a possible differential response to treatment. 
 
Explanations of secondary findings  
Equal effect sizes were found across vaginal pain types for pain reduction; this could 
be understood using a biopsychological model. As discussed in the introduction, 
commonalities  exist  in  terms  of  the  psychological  responses  to  pain  across 
conditions,  including  anxiety,  fear/avoidance,  depression  and  hypervigilance; 
therefore,  psychological  treatment  could  help  to  address  such  factors  which 
maintain and exacerbate pain. A biopsychological model would assume that shared 
features amongst the vaginal pain conditions could respond similarly to treatment. 
Vaginismus trials with pain outcomes are needed to confirm this argument as most 
are focused on sexual and psychological functioning. Reasons for excluding pain as 
an outcome were not given, but as discussed, it could be due to vaginismus being 
classified a sexual dysfunction, rather than a pain disorder (DSM-IV-TR, 2000). This 
may change in conjunction with the new GPPPD classification (APA, 2013), which 
acknowledges pain as one of four components of a penetration problem.  
 
Equal effect sizes in general sexual function were also found across vaginal pain 
types, but a discrepancy occurred when focusing specifically on frequency of sexual 
activity. Vaginismus populations improved on this outcome, whereas vulvodynia did 
not. One hypothesis for this differential effect could be that psychological treatments 
for  medically  defined  pain  focus  exclusively  on  pain  management  and  discount 47 
factors  such  as  arousal  and  desire,  which  may  influence  sexual  frequency. 
Treatment  for  vaginismus  may  be  grounded  in  a  more  holistic  psychological 
approach to sexual experience (Masters & Johnson, 1966, 1970; Winze & Carey, 
2001). However, this does not account for the large effects found for general sexual 
functioning and small or no effects found for sexual frequency. Sexual function and 
frequency  are  somewhat  wide-ranging  and  ambiguous  outcomes.  Better-defined 
outcome measures and dismantling studies could help inform which aspects of the 
programme influenced the various aspects of sexual functioning.    
 
Limitations  
The conclusions of this review should be considered in light of several limitations, as 
well as the variability in the quality of studies outlined above. The sample sizes in 
most  of  the  included  studies  were  small  compared  to  other  RCTs  that  have 
evaluated treatment for pain conditions. In a review of psychological therapies for 
chronic pain, studies were excluded if they contained fewer than 20 participants per 
treatment arm (Williams, Eccleston & Morley, 2012). If this rule were applied to the 
current review, six of the included studies would have been excluded. The small 
sample sizes observed across studies could suggest difficulty with recruitment. This 
cannot be explained by prevalence rates alone, as pain during sex is experienced 
by approximately 17% of women; however, the rate of help-seeking populations of 
women with sexual difficulties is as low as 22% (Moreira et al., 2005). In addition to 
small samples, a maximum of three studies were included in any one meta-analysis 
due to the heterogeneity of treatments and outcomes. Together, these factors result 
in  an  increased  risk  of  type  2  error  (false  negatives),  and  compromise  the 
generalisation of findings and make it challenging to form a clear picture of efficacy. 
Larger studies would help to detect smaller effects and draw firmer conclusions. The 
majority of studies compared two or more active treatments; only two studies used a 
control condition. Without controls, only equality in effectiveness can be concluded. 48 
No  vulvodynia  studies  compared  treatment  to  a  control;  therefore  it  cannot  be 
concluded that psychological treatments are better  than no treatment. Moreover, 
when  comparing  size  of  effects  between  studies,  it  is  hard to  ascertain  whether 
differences are attributable to the treatment itself, rather than a feature of the trial 
design. 
  
This review did not include other vaginal pain conditions without identifiable organic 
causes that can also affect sexual function, such as chronic pelvic pain and deep 
dyspareunia (Verit, Verit & Yeni, 2006). As previously mentioned, the new GPPPD 
diagnosis (DSM-5; APA, 2013) could embrace such conditions on the basis that 
they  interfere  with  the  ability  to  engage  in  penetrative  behaviours. Widening  the 
inclusion criteria for vaginal pain populations would have allowed for more a robust 
analysis and an exploration of analogous or differential treatment effects for all pain 
problems linked to sexual dysfunction. 
 
Clinical and research implications 
This  review  has  highlighted  a  lack  of  studies  that  compared  psychological  and 
medical treatments for psychiatrically defined conditions, and a lack of studies that 
used a control condition for the medically defined conditions. Only one study used 
an integrated medical and psychological treatment approach.  
 
It has long been debated whether psychiatrically or medically defined vaginal pain 
problems should remain separate (Binik, 2005), and with the new GPPPD diagnosis, 
more research into integrative classifications and treatment approaches could help 
to improve care for pain-induced sexual dysfunction. Multicomponent models of pain 
have  been  investigated  and  applied  to  vulvodynia,  mainly  in  the  form  of  pain 
management  programmes  (Sadownik,  Seal  &  Brotto,  2000;  Munday,  Buchan, 49 
Ravenhill, Wiggs & Brooks, 2007); but these have not used controlled methodology, 
nor  considered  the  relative  impact  of  psychological  and  physiological  treatment 
components  on  pain.  It  could  be  helpful  to  investigate  multimodal  treatment 
approaches, by varying the proportion of psychological and medical input to see 
whether  differential  effects  are  found.  Or,  vaginal  pain  could  be  placed  on  a 
spectrum; at one end would be women with no identifiable physiological cause and 
significant  psychological  difficulties,  and  on  the  other  end  would  be  women  with 
clear physiological causes and few psychological difficulties (although physiological 
causes are not always detectable, Lonkey et al., 2011). Along this spectrum, effects 
of treatment could be explored to help determine what type of treatment is suitable 
for  varying  presentations.  Vaginal  pain  conditions  falling  in  the  middle  of  the 
spectrum  may  benefit  most  from  a  combination  of  medical  and  psychological 
interventions, and it would be useful for larger controlled trials could examine both 
singular  and  multicomponent  treatments.  Qualitative  research  could  supplement 
this,  to  help  understand  experiences  and  treatment  preferences  of  women  with 
vaginal pain. 
 
This review was based on a small number of trials, several of which were low in 
quality. However, psychological and medical treatments were found to be equally 
effective in improving pain and sexual functioning for medically defined vaginal pain. 
If  this  finding  it  supported  by  further  research,  it  could  be  argued  that  the  less 
invasive method of treatment should be offered first. NICE guidelines for  mental 
health conditions (e.g. depression & generalised anxiety disorder) often sequence 
treatment options in terms of invasiveness, recommending non-medical options first 
if treatments are equally effective (NICE, 2009; 2011). Applying a biopsychological 
understanding of vaginal pain and allowing patients a choice of treatments, could 
also help to improve outcomes. 50 
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Part 2: Empirical paper 
The effectiveness and acceptability of a computerised guided self-
help programme for vaginismus: a mixed methods design 
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ABSTRACT  
Aim: To evaluate the effectiveness and acceptability of a computerised guided self-
help programme for women with vaginismus. Method: Six women with vaginismus 
followed  a  behavioural  programme  delivered  online  and  supported  by  weekly 
telephone  calls.  A  multiple  case  design  was  used  to  quantitatively  evaluate 
effectiveness  on  primary  outcomes  of  penetration,  pain-related  fear  and  pain 
intensity. Data were analysed using: 1) graphical representations, 2) correlations, 3) 
the  reliable  change  index,  and  4)  benchmarking.  A  thematic  analysis  on  post-
treatment  interviews  was  undertaken  to  examine  acceptability  and  change 
experienced as a consequence of the programme. Results: Over the course of the 
programme,  pain-related  fear  reduced  and  successful  penetration  attempts 
increased; these outcomes were strongly correlated. Pain on penetration reduced, 
but was low in intensity from initial attempts. At the end of treatment, three women 
had successful intercourse; two successfully used objects to penetrate; and one did 
not improve significantly. The programme was experienced as easy to access, use 
and understand. The progressive nature of the programme and clinical support was 
found to be helpful, although frustration was experienced when progress was slow. 
Other themes found were: increased self-awareness and confidence, normalisation, 
and  a  willingness  to  approach  the  problem  rather  than  avoid  it.  Exposure  to 
penetration was identified as the most difficult but most important aspect of change. 
Conclusions: A guided computerised programme is an acceptable and effective 
way to treat vaginismus. Larger  scale studies  could  evaluate  whether  its clinical 
effectiveness is comparable with face-to-face interventions, and if so it could be an 
economical alternative intervention. 
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INTRODUCTION 
Vaginismus  is  a  female  sexual  dysfunction,  which,  according  to  the  DSM-IV-TR 
(APA, 2000) can be diagnosed if a woman experiences a ‘recurrent or persistent 
involuntary  contraction’  of  the  outer  vaginal  muscles  in  response  to  attempted 
penetration. The involuntary contraction is a physiological response that restricts the 
vaginal  passage  and  makes  penetration  painful  or  unachievable.  Although  the 
response is physical, the cause is not explained by medical or physiological factors. 
Some women develop vaginismus when they first become sexually active (classified 
as  lifelong)  and  others  develop  it  following  a  specific  experience  (classified  as 
acquired). The 2000 classification was recently revised in the DSM-5 (APA, 2013), 
in which dyspareunia (‘recurrent or persistent genital pain associated with sexual 
intercourse’;  APA,  2000)  and  vaginismus  were  merged  into  a  new  diagnostic 
category termed ‘genito-pelvic pain/penetration disorder’ (GPPPD), covering a wider 
range of pain and penetration problems. This change arose from a lack of evidence 
for  exclusivity  between  the  two  diagnoses  (Binik,  2010a,  2010b),  in  addition  to 
problems accurately identifying vaginal muscle contractions as a diagnostic factor 
(Reissing, Binik, Khalife, Cohen & Amsel, 2004). This new GPPPD diagnosis will 
take time to permeate relevant NHS settings and diagnostic criteria for vaginismus 
are still being used today. The current research was initiated before the DSM-5 was 
published, therefore, the population studied focused on vaginismus.  
 
Large  population  surveys  have  demonstrated  prevalence  rates  of  sexual 
dysfunctions in females (including problems with pain, lubrication, arousal, desire 
and orgasm) in the range of 44-51%, with vaginal pain problems comprising 12-17% 
(Moreira et al., 2005; Shifren et al., 2009; Vahdaninia, Montazeri, & Goshtasebi, 
2009). This does not reflect the prevalence of vaginismus per se, as problems could 
include chronic pain conditions, such as vulvodynia, which can interfere with sexual 
function.  However,  Spector  and  Carey  (1990)  found  a  similar  rate  (16%)  of 66 
vaginismus in women attending sexual health clinics. In the general population, a 
more conservative estimate of 1% has been suggested (Winze & Carey, 2001). 
 
There is a lack of evidence for predictors of vaginismus, but associated cognitions 
have been found. These include: catastrophising about pain, holding a negative self-
image,  fearing  intimacy,  fearing  loss  of  control  and  feeling  disgusted  about  sex 
(Borg,  Peters,  Schultz  &  de  Jong,  2012;  de  Jong,  Overveld  &  Schultz,  2009; 
Reissing, 2012). Such beliefs may have existed prior to the problem, creating a 
susceptibility to developing vaginismus. But most research has explored beliefs in 
populations in which the problem is established; therefore, cognitions may serve to 
maintain the fear-pain response. Although cognitive explanations can be useful for 
understanding  idiosyncratic  presentations  and  applying  CBT  techniques,  the 
evidence  for  treatment  suggests  a  powerful  behavioural  component  (ter  Kuile, 
Lankveld, de Groota, Melles, Neffs & Zandbergen, 2007).  
 
Wijma and Wijma (1997) put forward a behavioural model (Figure 2), which includes 
components of classical and operant conditioning. Initially an association is formed 
between  penetration  (unconditioned  →  conditioned  stimulus)  and  pain 
(unconditioned → conditioned response). Thereafter, the response is maintained by 
negative  reinforcement  (avoidance  of  pain).  This  model  recognises  that  internal 
events  strengthen  and  maintain  the  avoidance  response,  including  mood  states 
(e.g. fear) and unhelpful cognitions. Once avoidance of penetration is established, 
sexual functioning is impaired. 
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Figure 2: Behavioural model of vaginismus  
 
A behavioural understanding of vaginismus has been used to develop treatment 
approaches, such as graded exposure (described below). Presently, there are no 
evidence-based guidelines to specifically inform the treatment of vaginismus; but the 
British  Association  for  Sexual  Health  and  HIV  recommend  routinely  treating 
vaginismus with behavioural intervention (Crowley, Richardson & Goldmeier, 2006). 
Behavioural  techniques  can  be  supported  by  cognitive  strategies  (e.g.  targeting 
associated  cognitions)  to  help  reduce  fear  and  encourage  approach  behaviours. 
Cognitive-behavioural  approaches  have  been  commonly  evaluated  in  controlled 
clinical trials on vaginismus (Melnik, Hawton & McGuire, 2012).  
 
Typically  treatment  involves  five  main  components  (Hawton,  1985;  Jeng,  Wang, 
Chou, Shen & Tzend, 2006; Masters & Johnson, 1970; Winze & Carey, 2001) as 
follows:  
1) Education. This component helps the person (and her partner) to understand 
and  normalise  the  problem.  Education  in  itself  can  help  to  alleviate  anxiety  and 
establish rationale and motivation for treatment.  
2)  Relaxation.  As  a  fear-driven  disorder,  vaginismus  is  characterised  by  sexual 
anxiety, but is also frequently co-morbid with general anxiety (Watts & Nettle, 2010). 
Therefore, learning how to identify tension and relax muscles is an important part of 
the treatment. As vaginismus is accompanied by avoidance, relaxation can be a 
gentle way to re-introduce self-focus.  68 
3)  Pelvic  floor  exercises.  These  exercises  are  introduced  to  teach  women  to 
differentiate between sensations of contracting and relaxing the muscles around the 
vagina. Pelvic floor exercises help to increase awareness of vaginal tension and can 
also help to increase a sense of control, both of which can help when penetration is 
attempted (Kegel, 1948).  
4) Sensate focus. This involves exploration of bodily touch without the pressure of 
penetrative activities. Removing penetration from sexual activity allows women to 
build confidence (with themselves and their partners) and enjoy a tactile experience 
without a fear of pain.  
5) Exposure. Women are asked to insert objects of graded sizes (called trainers) 
into  their  vaginas.  Introducing  the  physiological  sensations  of  penetration 
(conditioned  stimulus)  with  reduced  anxiety  (habituation)  helps  to  eliminate  the 
vaginal spasm (conditioned response) that causes the pain (Masters & Johnson, 
1970).  When  women  are  comfortable  using  the  trainers,  a  transition  to  sexual 
intercourse  can  be  made.  Graded  exposure  has  been  argued  to  be  the  most 
important component for driving behaviour change (ter Kuile et al., 2007; 2009). 
 
Due  to  the  multi-factorial  treatment  for  vaginismus,  the  relative  impact  of  each 
component remains unclear. Some have argued that outcomes can be predicted by 
factors  external  to  treatment,  such  as  the  quality  of  the  patient’s  relationship  or 
motivation  of  the  patient’s  partner  (Hawton,  1995).  Melnik,  Hawton  &  McGuire 
(2012)  undertook  a  systematic  review  examining  the  efficacy  of  psychological 
treatment  for  vaginismus.  From  five  trials  that  were  included,  no  significant 
differences were found between treatment types. Due to the small number of trials, 
the authors suggest that the findings should be interpreted cautiously. Larger trials 
could  help  to  identify  smaller  treatment  effects.  The  largest  trial  included  in  the 
review examined 117 women with lifelong vaginismus (Van Lankveld, ter Kuile, de 
Groot, Melles, Nefs & Zandbergen, 2006). It compared group CBT, bibliotherapy 69 
and waiting list control. Both treatment conditions used a self-help manual, but the 
bibliotherapy group only had minimal contact with a professional (brief weekly phone 
calls, as opposed to weekly CBT groups). The study reported that both treatment 
arms led to successful vaginal intercourse; interestingly, more so in the bibliotherapy 
(18%) than the CBT group (9%) and control (0%) post-treatment. This effect was 
maintained at 12 months, in which the rate of successful vaginal penetration in the 
CBT group was 21% and in the bibliotherapy 15%. Support for bibliotherapy has 
also  been  evidenced  in  another  RCT,  in  which  self-reported  complaints  reduced 
following treatment (van Lankveld, Everaerd & Grotjohann, 2001).  
There is limited good quality evidence despite vaginismus being recognised 
as a prevalent sexual dysfunction. Overall, results from these trials evidence do not 
evidence a high rate of success, but show that self-help in the form of bibliotherapy 
is a plausible alternative to face-to-face treatment. 
 
A large global study of sexual attitudes and behaviours revealed that 44% of women 
with a sexual problem did not seek help (Moreria et al., 2004). Of those who did, 
16% did so via anonymous routes (such as books, helplines or the internet), which 
is similar to the rate of people who sought help from a doctor (19%). Shrifen et al., 
(2009) found a higher rate of help-seeking via professionals (35%) most of whom 
were gynaecologists or GPs; however, only 6% specifically visited their doctor to 
address the sexual problems and most women preferred the clinician to initiate the 
conversation.  Several  reasons  for  not  seeking  help  include:  embarrassment, 
concern that the doctor would be uncomfortable, not having enough time, not being 
asked by a clinician, and not seeing the problem as serious or treatable (Moreria et 
al., 2004; Vahdaninia et al., 2009). Barriers to help-seeking are wide-ranging, but 
seem to relate to a shared anxiety of disclosure. Help-seeking behaviours may also 
be culturally dependent. 
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In  the  past  decade,  a  surge  of  health  related information  has  become  available 
online. Patients often use the internet to investigate possible causes and treatments 
for  their  symptoms,  instead  of  or  before  seeking  professional  help  (Ybarra  & 
Sunman, 2006). This mode of help-seeking may be particularly pertinent for those 
who are embarrassed to talk about their difficulties, but also for those who have less 
time or resource to attend appointments; information can be accessed immediately. 
Numerous computer-based self-help programmes have emerged in the past decade 
for the treatment of anxiety and depression, and have been found to be a highly 
acceptable  mode  of  treatment  based  on  adherence  rates  (80%)  and  overall 
satisfaction  (86%)  (Andrews,  Cuijpers,  Craske,  McEvoy  &  Titov,  2010). 
Computerised interventions targeting sexual behaviour have also been reviewed, 
and show stronger effects than face-to-face interventions at improving knowledge of 
sexual health, as well as a small effect on promoting safer sex (Bailey et al., 2010).  
 
There is a lack of validated computer-based programmes for sexual dysfunction, 
and  so  far  no  computerised  interventions  specifically  for  vaginismus  have  been 
formally evaluated. Some women may access information on the internet, and there 
are  websites  that  offer  purchasable  self-help  guides  (www.vaginismus.com)  and 
blogs,  which  aim  to  support  women  (www.livingwithvaginismus.blogspot.co.uk). 
However, it is unclear how the guides were developed and whether or not they are 
effective. 
 
From examining the evidence base for vaginismus and the use of computerised 
interventions,  a  computer-based  self-help  programme  could  be  an  accessible, 
effective an acceptable way of treating vaginismus. The current research aimed to 
answer the following questions: 71 
1.  Following the use of a computerised self-help programme for vaginismus, 
will there be a change in:  ability to achieve penetration, intensity of pain, 
pain-related fear, general anxiety and relationship satisfaction? 
2.  Will a computerised self-help programme for vaginismus an acceptable and 
helpful form of treatment for participants who experienced it? 
 
METHODS 
Participants  
Participants were six women seen in an inner London genitourinary medicine clinic 
(see Table 1 for demographics). All participants were assessed by a gynaecologist 
or sexual health specialist and diagnosed with vaginismus. Women were included if 
they were over 18 years old and had capacity to consent. Relationship status and 
heterosexuality were not inclusion criteria because the programme was designed so 
that penetration could be achieved with or without a penis. Women were excluded if 
they were: pregnant; starting, undergoing or completing menopause (as pain can be 
related  to  changes  at  this  stage);  insufficiently  fluent  in  English  to  read  and 
understand the self-help guide; did not have access to a computer at home or were 
unable to use a computer. Women with vaginal pain on penetration due to other 
factors for example, tissue or nerve damage, sexually transmitted infections, urinary 
tract infections, lack of lubrication) would be excluded from a vaginismus diagnosis. 
 
Of eight women who consented and started the programme, two dropped out. One 
moved  abroad  three  weeks  into  the  programme  and  contact  could  not  be 
maintained.  The  other  went  abroad  for  a  month  after  two  weeks  of  starting  the 
programme and did not re-engage on her return.  72 
 
Table 4 
Participant demographics 
ID  Age  Ethnicity  Type  Last  
attempt at 
sexual 
intercourse 
Pain rating 
for last 
penetration 
attempt  
Relationship 
status 
Previous 
treatment 
P1 
 
30s  White 
European 
Lifelong   8 months   10/10 
(intercourse) 
Heterosexual 
relationship 2 
years 
None 
 
P2 
 
20s  White 
European 
Acquired 
(1 year) 
3 days   10/10  
(intercourse) 
Heterosexual 
relationship 
3.5 years  
None  
P3 
 
30s  White 
European 
Lifelong   1 month   5/10 
(trainer 4) 
Not in a 
relationship  
Trainers 
self-
directed  
P4 
 
30s  White 
European 
Acquired 
(3 years) 
2 months   5/10 
(intercourse) 
Heterosexual 
relationship 2 
years 
Vibrator 
self-
directed  
P5 
 
20s  White 
British 
Lifelong  1 month   5/10  
(intercourse) 
Heterosexual 
relationship 6 
months 
Trainers 
self-
directed 
P6 
 
<20  Asian 
British 
Acquired 
(3 
months) 
4 days   8/10  
(intercourse) 
Heterosexual 
relationship 3 
months 
None  
 
Process 
Participants  were  offered  a  choice  between  standard  care  (face-to-face 
psychological therapy) and the computerised self-help programme. It was explained 
to participants that the difference between treatments was the mode of delivery, not 
the content. Participants were given an information sheet (Appendix 3) and were 
allowed  one  week  to  consider  their  choice.  If  they  opted  for  the  computerised 
programme they were invited to attend an initial meeting with the researcher. This 
meeting  lasted  approximately  45  minutes  and  involved:  explaining  the  treatment 
process in detail, obtaining consent (Appendix 4), demonstrating how to use the 
programme,  giving  participants  trainers  (supplied  by  the  clinic)  and  completing 
baseline questionnaires.  
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Based  on  previous  research  (van  Lankveld  et  al.,  2006),  the  programme  was 
designed to run for 6-8 weeks, with the possibility to extend to 9 weeks depending 
on the pace of the individual. If by 9 weeks participants had not achieved their goals, 
they were invited to have a review with the researcher and their care was continued 
in the GUM clinic if necessary. Weekly telephone contacts with the researcher of 15-
20 minutes were scheduled as part of the intervention. 
 
Intervention 
The  self-help  programme  was  developed  using  existing  literature,  consisting  of 
textbooks, articles and empirical research pertaining to specific clinical techniques. 
A bibliotherapy guide used in a previous RCT (van Lankveld et al; 2006) was also 
obtained from the authors and translated to help inform the current programme. As 
a  predominantly  behavioural  intervention,  behaviour  change  techniques  were 
integrated  to  try  to  promote  change,  including:  goal-setting,  goal-review,  self-
monitoring, feedback, behavioural practice, graded tasks and self-reward (Abraham 
& Michie, 2008). A draft of the programme was sent to specialists in the field (sexual 
health clinicians and researchers) for consultation. Feedback from six specialists 
was collated and revisions were made accordingly.  
 
The  programme  was  developed  and  run  using  internet  based  software  Prezi 
(www.prezi.com). This software facilitates the development of a mind-map, in which 
information and key concepts are linked together in a simple sequential way, using 
text, diagrams and video. The steps in the programme were set out visually on a 
pathway (see Appendix 5 for a screenshot of the programme). 
 
The following components were included in the programme.  
  Step  1:  Educational  material.  This  step  explained  the  diagnosis  of 
vaginismus, explored possible causal factors and maintenance cycles, used 74 
anatomical  diagrams  to  demonstrate  physiological  change,  and  included 
fictional  vignettes  about  experiences  of  vaginismus.  Participants  moved  to 
Step 2 when they had finished all of the reading. 
  Step 2: Relaxation and pelvic floor exercises. This step asked participants 
to introduce relaxing activities into their routine, as well as practising more 
formal relaxation techniques. Progressive muscle relaxation was implemented 
to help participants notice differences between muscle tension and relaxation, 
and become more aware of tension held throughout the body. The pelvic floor 
exercises aimed to increase identification of tension specifically in the vaginal 
area  and  to  promote  a  sense  of  control  over  these  muscles.  Participants 
moved to Step 3 when they had tried progressive muscle relaxation three or 
four times, had done pelvic floor exercises every day for at least a week and 
were able to notice differences in tension and relaxation. 
  Step  3:  Body  awareness.  This  step  required  participants  to  explore  their 
body  using  touch  and  massage,  either  alone  or  with  their  partners.  Body 
awareness specifies that no penetrative activities should take place during this 
exercise, in order to remove any related fear or pressure. Encouraging sexual 
exploration whilst feeling relaxed can help to build confidence and allow for an 
enjoyable sensual experience. This aimed to help women feel more prepared 
for the final stage of the programme. Participants were given the choice of 
whether or not to undertake body awareness because some women already 
feel  confident  with  touching  their  bodies.  Those  who  chose  to  do  body 
awareness, moved to Step 4 when they had tried it three or four times and felt 
ready to move on to the trainers.  
  Step  4:  Exposure.  This  step  involved  gradual  exposure  to  penetration  to 
familiarise participants with the sensations of objects contained in their vagina 
whilst feeling relaxed. Women chose to start using their fingers or trainers. 
The size of the object contained was increased slowly and women only moved 75 
on to the next sized object when they could contain the previous object with 
no  pain  or  minimal  discomfort.  Most  participants  aimed  to  attempt  sexual 
intercourse; therefore, the transition between the trainers and their partner’s 
penis was made. Participants without partners could choose to transition to a 
vibrator,  which  mimics  sexual  intercourse  more  closely  than  the  trainers. 
Treatment ended when participants were able to have successful penetration 
either with their partner’s penis (or a vibrator if no partner) or if the participant 
reached the 9 week maximum duration period.  
 
Participants received a telephone call each week for the duration of the programme 
from the researcher (trainee clinical psychologist). The first call occurred on the day 
that participants gained access to the programme and focused on setting goals for 
the  ensuing  6-8  weeks.  All  calls  made  after  the  first  contact  followed  a  similar 
informal  structure.  First,  diary  activity  (self-monitoring)  from  the  week  was 
discussed, in terms of what activities were undertaken and reflecting on the fear and 
pain scores. Second, any difficulties or points of interest identified were explored 
using a problem-solving approach. Third, goals were reviewed and feedback was 
given  regarding  the  progress  of  the  participant.  Fourth,  a  plan  was  made 
collaboratively for the upcoming week. Finally, participants had the chance to ask 
any final questions. The researcher undertaking the telephone contacts had regular 
supervision from a senior clinical psychologist.  
 
Ethical approval for the evaluation of this intervention was obtained from the Central 
London NRES Committee (Ref: 13/LO/0487; Appendix 6). 
 
Quantitative outcomes 
The programme was evaluated using several outcome measures selected on the 
basis of functional and psychological factors experienced with vaginismus.  76 
 
The following two outcomes were collected daily for the duration of the programme. 
Data  were  collected  using  online  diaries;  each  participant  had  an  anonymous 
account and entered outcomes in code to preserve confidentiality. 
  Pain-related fear. As fear maintains avoidance in vaginismus, a fear score 
was  collected  daily  throughout  the  programme,  in  addition  to  a  week  of 
baseline scores. Participants were asked to rate how fearful they were of pain 
associated with penetration on a scale from 0-10, 0 being ‘not at all fearful’ 
and 10 being ‘extremely fearful’. Psychometric properties of this exact scale 
have not been previously evaluated; however, a similar scale used in a trial of 
vaginismus found good internal consistency (α =0.82) and test-retest reliability 
(r =0.73; ter Kuile et al., 2007).   
  Programme activities. To monitor the frequency  and duration of  activities 
included  in  the  programme,  participants  recorded  what  activity  they  tried, 
whether or  not it was successful, and how long they did it for. Embedded 
within  this  information  were  questions  from  the  Primary  Endpoint 
Questionnaire  (PEQ;  van  Lankveld  et  al.,  2006;  Appendix  7).  The  7-item 
measure looks at whether penetration on a range of levels (self or partner one 
finger  or  two  fingers,  other  objects  inserted  by  self  or  partner  and  sexual 
intercourse)  was  attempted  and  successful  in  the  past  4  weeks.  Scores 
ranged  from  0-7;  successful  or  partially  successful  attempts  scored  1  and 
unsuccessful or no attempt scored 0. Internal consistency of the PEQ has 
been  found  to  be  satisfactory  (α  =  0.72).  The  PEQ  was  adapted  to 
accommodate the use of trainers instead of fingers, and for women who did 
not  have  partners  as  follows:  one  finger  scored  equivalently  to  trainer  1 
(smallest),  two  fingers  equivalently  to  trainer  2  (second  smallest),  other 
objects equivalently to trainers three and four, and intercourse equivalently to 
a  vibrator.  PEQ  scores  for  P4  were  also  prorated  to  account  items  that 77 
required  a  partner’s  finger.  P4  had  a  successful  smear  test  during  the 
programme which was coded as successful object inserted by other.  
 
Pain was rated every time the participant engaged in a penetrative behaviour. 
  Intensity of vaginal pain. As pain is associated with attempted penetration in 
vaginismus, a pain rating was collected throughout the programme on days 
that penetration activity occurred. Pain was measured on a numerical rating 
scale  from  0-10,  0  being  'no  pain'  and  10  being  worst  possible  pain' 
(McCaffery  &  Pasero,  2001).  Moderate  construct  validity  (r=0.85;  Ritter, 
González, Laurent & Lorig, 2006) and test-retest reliability (r=0.90) has been 
found (Lundeberg et al., 2001). 
 
Two further outcome measures were administered at baseline, mid-treatment and 
post-treatment. 
  Anxiety.  Heightened  anxiety  is  associated  with  women  with  vaginismus 
(Watts  &  Nettle,  2010).  The  GAD-7  is  a  seven-item  measure  of  general 
anxiety, which examines worry, nervousness, restlessness, irritability, trouble 
relaxing, and feeling afraid or panicked. Scores range from 0-21, and the cut-
offs  used  were:  0-4  (none),  5-10  (mild),  11-15  (moderate),  15-21  (severe) 
(Department  of  Health,  2011).  The  GAD-7  has  been  found  to  have  good 
internal consistency (Cronbach's α=0.89; Lowe et al., 2008), high test-retest 
reliability (0.83) and optimal levels of sensitivity and specificity (89% & 82% 
respectively; Spitzer et al., 2006).  
  Relationship  satisfaction.  Interference  with  sexual  function  can  impact 
considerably  on  relationships  (Byers,  2005).  For  participants  who  were  in 
relationships the Couples Satisfaction Index (CSI-16; Funk & Rogge, 2007) 
was  administered.  This  is  a  16-item  measure  that  examines  the  extent  to 
which  the  relationship  offered  happiness,  strength,  comfort,  reward, 78 
satisfaction and other emotional aspects. It gives a single score between 0-81 
and has been found to have high levels of internal consistency (α= 0.98) and 
strong  convergent  validity  with  other  existing  measures  (Funk  &  Rogge, 
2007). 
 
Qualitative outcomes 
As  this  programme  used  a  novel  mode  of  treatment  delivery,  semi-structured 
interviews  were  used  to  gain  a  more  in-depth  understand  of  participant’s 
experiences.  All  interviews  were  conducted  within  a  week  of  finishing  the 
programme  and  aimed  to  explore  two  broad  domains:  1)  Acceptability  of  the 
programme (e.g. likeability, usability, comprehensibility & the process of treatment), 
and 2) what changes occurred as a consequence of the treatment and why. The 
interview schedule included acceptability questions derived from feasibility research 
(Brug, Schaalma, Kok, Meertens & Van der Molen, 2000; Collings et al., 2012). The 
interview  also  encompassed  questions  from  the  Client  Change  Interview  (Elliott, 
Slatick  &  Urman,  2001;  Appendix  8),  which  explored  aspects  of the  programme 
participants found helpful or difficult, changes they noticed in themselves, what was 
attributed to change, as well as a question on suggested improvements. 
 
Design 
A multiple-case literal replication design was used to measure quantitative change. 
This design uses the same methodology as a single-case design, but is considered 
more  robust,  as  a  larger  sample  size  allows  for  the  replication  of  findings  (Yin, 
1994). Literal replication means that similar outcomes are predicted for each case 
because they are selected for their likeness. In this research, similarity was defined 
on the basis of the specified inclusion and exclusion criteria, and adherence to the 
programme.  This  design  uses  a  small  number  of  participants;  therefore,  typical 
sampling logic does not apply. The aim is not to generalise to the target population, 79 
but to closely explore a theory and practice-derived application over time. Yin (1994) 
suggests at least 2-3 cases are required to provide compelling data, or enough to 
reach saturation. To account for the small sample, a larger number of data points 
are collected.  
  The qualitative data would be used to understand further the acceptability of 
the programme and a more in-depth account of change. This follows a  ‘partially 
mixed sequential dominant status design’ (Leech & Onwuegbuzie, 2009), as the two 
methods of data collection are undertaken  sequentially, and greater emphasis is 
placed on the quantitative outcomes. 
 
Quantitative analyses  
The data were analysed in four ways: 
1.  Graphical representation. Change was observed graphically for outcomes 
collected for the duration of the programme. This method has been used in 
single-case analyses to infer change based on observed scores following the 
introduction of an intervention (Barlow, Nock & Hersen, 2008).  
2.  Correlation.  As  data  were  not  normally  distributed,  Spearman  rank 
correlations were used to calculate associations between pain-related fear 
and penetration for each participant.  
3.  Reliable  Change  Index.  All  outcomes  were  analysed  using  the  reliable 
change index (RCI; Jacobson & Truax, 1991). The RCI calculates whether 
individual participants improved, did not change or deteriorated between two 
time points. Internal consistency coefficients were used to calculate reliable 
change  scores;  if  unavailable,  test-retest  reliability  was  used.  Reliable 
change criterion for all outcomes can be found in Table 5. 
4.  Benchmarking.  Effect  sizes  were  calculated  and  compared  to  previous 
RCTs on outcomes of penetration and fear to help determine whether levels 
of change were meaningful. Effect sizes for pre-post change were used.  80 
 
Table 5 
Reliable Change Criterion for all outcomes 
Outcome 
measure 
(range) 
Mean at 
assessment 
Standard deviation 
at assessment/ 
standard error of 
change 
Reliability coefficients   Reliable 
Change 
score* 
PEQ 
(0-7) 
1.71  0.95 / 0.34  Internal consistency 
0.72 (van Lankveld et 
al., 2006) 
1.39 
GAD-7 
(0-21) 
9.71  6.65 / 3.12  Internal consistency 
0.89  (Spitzer et al., 
2006) 
6.11 
CSI 
(0-81) 
63.33  16.87 / 3.37  Internal consistency 
0.98 (Funk & Rogge, 
2007) 
6.61 
Pain scale 
(0-10) 
7.14  2.27 / 1.02  Test retest reliability 
0.90 (Lundeberg et 
al., 2001) 
1.99 
Fear scale 
(0-10) 
7.71  1.60 / 1.18  Test-retest 0.73 (ter 
Kuile et al., 2007) 
2.30 
Note: *The level of change necessary on each outcome to detect a reliable change  
 
Qualitative analysis  
Interviews were transcribed verbatim. Qualitative data were used to understand the 
experience of the programme in detail and to explore factors that were not captured 
by quantitative outcomes. Interviews followed certain lines of enquiry (acceptability 
and  change),  so  thematic  analyses  were  conducted  under  these  pre-defined 
headings. Similar methods have been used in previous research, with a specific 
interest in uncovering themes that relate to acceptability (Finucane & Mercer, 2006) 
and change (Orford et al., 2006). Under the two broad headings of acceptability and 81 
change, themes were explored using Braun and Clarke’s (2006) suggested method 
for qualitative analysis. The following phases were carried out: 1) familiarisation with 
data; 2) generating initial codes; 3) searching for themes; 4) reviewing themes; and 
5) defining and naming themes. The software NVivo10 was used to help organise 
data  into  themes. To  enhance  the  credibility  of  the  analysis,  another  researcher 
examined all data and a consensus was reached (Barker & Pistrang, 2005).  
It  is  recommended  that  researchers  state  their  position  regarding  the 
research topic. I am a trainee in my late-twenties who has previously worked in a 
sexual health setting and implemented similar behavioural techniques with women 
with vaginismus. I hold the opinion that CBT is the most appropriate treatment for 
vaginismus.  As  the  author  of  the  computer  programme,  I  was  keen  for  it  to  be 
helpful; but, I did not hold the assumption that it would be a success, because no 
computer-based programmes have been evaluated previously.  
 
RESULTS  
Six  women  completed  the  programme.  Days  taken  to  complete  the  programme 
ranged  from  38-61  (M=54.8  days).  Least  time  was  spent  on  Step  1  (education) 
M=2.3 days; most time was spent on Step 4 (exposure) M=42.3 days (see Table 6). 
Three  women  chose  not  to  complete  Step  3  (body  awareness),  reporting  that 
comfort with bodily touch was not a problem for them. P1, P2 and P6 ended the 
programme when they were able to have full sexual intercourse with minimal or no 
pain. P3 had no partner so ended the programme when she was able to use her 
vibrator  comfortably.  P4  and  P5  had  not  attempted  intercourse  by  the  end  of 
treatment. P5 reported that she intended to attempt intercourse in the near future. 
P4  decided  to  continue  using  her  vibrator  until  she  felt  comfortable  before 
attempting intercourse. 
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Table 6 
Programme duration and penetration outcome 
 
Graphical representation 
Outcomes of pain-related fear and penetration (PEQ) were collected every day for 
the duration of the baseline and programme. Pain ratings were collected at every 
penetration attempt. These outcomes are represented graphically (Figure 3, Figure 
4 & Figure 5) and have been corroborated with diary activity and ethnographic data 
(notes from telephone sessions) to try to understand the observed patterns.   
 
ID  Baseline 
/treatment 
duration 
Days per 
phase  
(steps 1-4) 
Contact 
amount 
(number & 
total call 
duration)  
Hours of  
penetration 
exposure 
(excluding 
intercourse) 
Penetration 
at end of 
treatment 
(pain rating) 
P1  10 days 
52 days 
3, 14, 0, 45  8 calls 
(2.5 hours) 
10.6 hours  Intercourse 
(0/10) 
P2  8 days 
38 days 
1, 17, 7, 21  7 calls 
(1.9 hours) 
2.6 hours  Intercourse 
(0/10) 
P3  7 days 
60 days 
1, 7, 11, 48  10 calls + 1 
email (2.7 
hours) 
10.1 hours  Vibrator 
(1/10) 
P4  7 days 
61 days 
7, 7, 0, 56  9 calls + 1 
email 
(2.5 hours) 
8.9 hours  Vibrator 
(3/10) 
P5  8 days 
59 days 
1, 12, 0, 46  9 calls 
(2.6 hours) 
6.8 hours  Trainer 4 
(2/10) 
P6  8 days 
59 days 
1, 10, 11, 
38 
10 calls 
(2.6 hours) 
4.3 hours  Intercourse 
(2/10) 83 
Figure 3 shows pain-related fear ratings for all participants. A general downward 
trend can be observed, in  which fear reduced over  time.  All participants’ scores 
reduced by ≥50% subsequent to the exposure phase; the mean number of days 
penetration  activities  were  attempted  (before  ≥50%  reduction)  was  11.7,  but  the 
variance was substantial (SD= 9.8).  
When observing scores in the baseline, four participants seemed to have 
stable fear scores (P2, P3, P4 & P5), whereas the other two experienced a dip in 
fear before stabilising. P1 reported that this dip was due to knowing that treatment 
would commence soon. P6 reported that talking about the programme made her 
feel less fearful of intimacy with her partner during the baseline period.  
When observing the patterns of change during treatment, some shifts in fear 
appear quite erratic. In some cases this was accounted for by the introduction of 
new stages of the programme. For example, P4’s fear drops from 9 to 0 on the first 
day that she attempted the trainers, doing so without any pain. Her scores increase 
again when attempting to use trainer 4, with which she made minimal improvement 
with  thereafter.  P1  shows  a  peak  of  pain-related  fear  near  the  end  of  the 
programme;  this  represented  the  first  time  she  had  successful  intercourse 
(corresponding pain score was 0). A more steady reduction in pain-related fear was 
observed for other participants. For P2 & P5 these reductions appeared to mirror 
successful attempts at using the trainers, but for P3 and P6 the reduction was not 
clearly  linked  to  specific  activities.  P3  reported  that  her  fear  of  at  the  end  of 
treatment remained at 2/10 because without a partner, she had not been able to 
attempt sexual intercourse.  84 
 
 
Figure 3: Pain-related fear scores for duration of programme 85 
 
Figure 6 shows penetration behaviours for all participants. It should be noted that as 
the PEQ assesses penetration over the last 4 weeks, scores are cumulative and 
therefore less erratic than the pain-related fear scores. A general upward trend can 
be observed, in which the number of successful penetration behaviours increases 
over time. Five participants’ scores increased by ≥50% in a mean number of 23 
days (SD=9.14). 
Around  week  three  (22-27  days)  all  six  participants  show  an  increase  in 
penetration  behaviour,  subsequent  to  steady  scores.  P1  increased  sharply  by  3 
points  when  she  attempted  trainers  1-4  all  in  one  day;  her  score  continues  to 
increase over the following weeks, accounted for by penetration activities with her 
partner  and  intercourse  at  the  end.  P2  demonstrated  a  steadier  increase  in 
penetration  behaviours,  increasing  the  sizes  of  trainers  and  partner’s  fingers 
progressively  over  time  and  ending  with  intercourse.  P3  and  P6  were  already 
engaging in some penetration behaviours before the programme started, so change 
was  less  remarkable.  P6  was  the  only  participant  who  was  attempting  sexual 
intercourse during the programme alongside the trainers; however, intercourse went 
from being unsuccessful at baseline to successful (indicated by 1 point increase at 
day 26). P5 had a temporary decline in functioning because she used trainer 4 for 
more than four weeks, so scores for the smaller trainers expired. P4 only increased 
one point in this scale, but in fact her use of trainers/vibrator led to an increase of 3 
points, whilst penetration activities with her partner decreased by 2 points.  86 
 
 
Figure 4: Penetration behaviours for duration of programme 87 
Pain ratings were collected on days when penetration activity was attempted. The 
programme was designed to prepare participants for comfortable penetration and 
this  resulted  in  pain  scores  tending  to  be  low  at  the  initial  penetration  attempt. 
Ratings from trainer 3 have been presented (Figure 5) because all participants used 
this trainer during the exposure phase. None of the women scored more than 2/10, 
and ratings tended to go down to 0/10 after several attempts. Initial attempts at 
trainer 4 were rated higher on pain (range 0-6), but after several attempts these also 
reduced to 2/10 or less in all women except P5 whose pain remained at 3/10.  
 
 
Figure 5: Pain ratings for trainer 3 
 
Correlations 
To evaluate associations between pain-related fear and penetration, scores for each 
participant  for  the  duration  of  the  programme  were  correlated.  All  correlations 
indicated  a  significant  strong  negative  relationship  between  fear  and  penetration 
(p<0.0001), which helps to confirm the observational data above. The strength of 
these  associations  could  indicate  a  dependability  of  the  two  variables  on  one 
another.  
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Table 7 
Correlations between pain-related fear and penetration 
Participant  Spearman’s 
r 
P1  -0.81 
P2  -0.94 
P3  -0.88 
P4  -0.78 
P5  -0.96 
P6  -0.84 
 
Reliable Change Index 
Change from baseline to end of treatment was evaluated using the Reliable Change 
Index.  When  fear  scores  in  the  baseline  phase  were  unstable,  the  score 
representing  the  highest  level  of functioning  was  selected  in  order  to detect  the 
smallest  amount  of  change.  Pre-treatment  pain  ratings  were  estimates  given  by 
participants of their last penetration attempt (intercourse or trainers). These related 
to  penetration  attempts  ranging  from  3  days  to  8  months  ago;  therefore,  the 
reliability of this outcome is questionable. End of treatment pain ratings were taken 
from the last penetration attempt of intercourse (P2, P3, P6), vibrator (P3, P4) and 
trainer 4 (P5). The graphs below represent three levels of change based on the 
reliability of each outcome. The top left triangle represents a reliable improvement; 
the  section  within  the  dotted  lines  represents  no  change;  and  the  bottom  right 
triangle represents a reliable deterioration.   
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Figure 6: RCI for pain-related fear 
 
 
 
 
 
 
Figure 7: RCI for pain 
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Figure 8: RCI for penetration behaviour 
 
 
 
       
Figure 9: RCI for anxiety 
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All participants showed a reliable improvement in pain-related fear (Figure 6). P4 
who  had  not  attempted  intercourse  by  the  end  of  treatment  still  experienced  a 
reduction in fear, possibly because she had some success using the smaller trainers 
and vibrator. However, on intensity of pain (Figure 7) P4 only showed a marginal 
improvement.  All  other  participants  demonstrated  a  reliable  improvement  in  pain 
intensity. Two women (P1 & P2) showed pain scores which decreased from 10 to 0. 
This seems an extreme change and could be explained by the inaccuracy of the 
pre-treatment rating; however, pre-treatment pain  was severe enough to prevent 
successful intercourse and post-treatment intercourse was successful and pain-free.  
 
Five of the six women improved reliably on penetration behaviours (Figure 8). It 
could be argued that this outcome is inherent in the exposure phase of treatment as 
patients are asked to engage in penetration behaviours; but, in order for these to be 
scored as ‘successful’ a low/tolerable level of pain is required or penetration cannot 
occur successfully (supported by pain ratings, Figure 5). 
 
General anxiety outcomes (Figure 9) showed that two women reliably improved and 
four women showed no change. General anxiety was not a specific target of the 
intervention,  but  the  programme  contained  techniques  that  focused  on  anxiety 
based  thoughts  and  physiology,  which  may  have  impacted  positively  on  general 
anxiety.  
 
Couples satisfaction outcomes were only available for four participants. For three 
participants (P2, P4, P5) no reliable change was found, but their baseline scores 
were already high (M=70.3, SD=0.6) indicating good relationship satisfaction from 
the outset. P6 reliably deteriorated on this outcome, but reported that this was not 92 
linked to sexual issues.  P3 was not in a relationship and P1 ended her relationship 
at the end of treatment, but also reported that this was not related to sexual issues.  
Benchmarking 
Table 8 includes pre-post treatment effect sizes for fear and non-coital penetration 
calculated from the current study and benchmarked against previous RCTs. These 
RCTs  were  selected  as  benchmarks  because they  used  similar  populations  and 
data were available on shared outcomes. Fear was benchmarked against an RCT 
that  evaluated  an  exposure-based  treatment  for  life-long  vaginismus  (Ter  Kuile, 
Melles, de Groot, Tuijnman-Raasveld & van Lankveld, 2013). Penetration behaviour 
was  benchmarked  against  an  RCT  that  evaluated  bibliotherapy  for  life-long 
vaginismus and reported on non-coital penetration (van Lankveld et al., 2006).  
 
The  RCTs  demonstrated  large  effects  on  pain-related  fear  and  penetration;  the 
current study also found large effect sizes for both outcomes. As a multiple-case 
design the effects of the current study are not intended to be representative of a 
wider population; however, it is useful to know that obtaining a large effect size is 
not unrealistic, when comparing to findings from controlled trials.  
 
Table 8  
Benchmarking pre-post effect sizes for penetration and fear 
Outcome  Pre-treatment 
M / SD (n) 
Post treatment 
M / SD (n) 
Effect 
size 
Pain-related fear 
 
RCT (ter Kuile et al., 2013) 
 
Current research 
 
 
3.10 / 1.11 (35) 
 
6.00 / 1.90 (6) 
 
 
 
1.98 / 0.92 (35) 
 
1.67 / 1.63 (6) 
 
 
 
d = 1.10 
 
d = 2.44 
Non-coital penetration  
 
RCT (van Lankveld et al., 
2006) 
 
 
 
0.8 / 1.4 (38) 
 
1.80 / 1.30 (6) 
 
 
2.3 / 1.8 (38) 
 
4.83 / 1.17 (6) 
 
 
d = 0.93 
 
d = 2.45 93 
Current research 
 
     
Qualitative analysis  
All six participants were interviewed at the end of the programme (M=26 minutes). 
Data were categorised under two broad headings (acceptability and change) and 
within these categories a general thematic analysis was undertaken (see Appendix 
9 for annotated example). Fourteen themes were found within five domains (see 
Table 9). The domains were informed by the types of questions asked and are as 
follows:  1)  Practicality  of  use,  which  discusses  experiences  of  the  interface  and 
usability of the programme; 2) Process of treatment, which examines the journey 
through  the  programme;  3)  Suggestions  for  improvement;  4)  Cognitive  changes 
identified;  and  5)  Behavioural  attributions  to  change  identified.  Themes  are 
supported by extracts from the interviews.   
 
Table 9 
Categories, domains, themes and sources 
Category  Domain  Theme  Number of 
sources  
Acceptability of 
programme  
1. Practicality of 
use 
1.1 Convenience 
1.2 Understanding the content  
1.3 Negotiating privacy 
6 
6 
3 
2. Process of 
treatment 
2.1 Steps to penetration 
2.2 Feeling supported 
2.3 Frustration at progress 
5 
6 
5 
3. Suggestions for 
improvement 
3.1 Easier way to navigate  
3.2 More information 
3.3 More clinician input 
3 
3 
3 
Change 
experienced 
through 
programme 
4. Cognitive 
change  
4.1 Awareness of self 
4.2 Normalising the problem 
4.3 Feeling more confident 
6 
5 
6 
5. Behavioural  5.1 Approach from avoidance  6 94 
attributions to 
change  
5.2 Trainers difficult but 
necessary 
6 
 
1.  Practicality of use 
Themes in this domain are focused on the practicalities of using the programme and 
relate primarily to interview questions on likeability, usability and comprehensibility 
(see Appendix 8).  
 
1.1 Convenience  
All six women reported that the programme was convenient to use because it was 
easy to access and/or it fitted flexibly into their routine. Ease of access often related 
to using the Prezi and completing the daily diary online. Fitting the programme into 
their  routine  was  described  as  flexible  because  they  could  undertake  programme 
activities  at  times  that  suited  them  and  did  not  have  to  attend  face-to-face 
appointments.  
 
 “I thought it was really easy. It didn’t take much time. It kind of gave you no 
excuses to do it because it was so easy [laughs] to use and do it.” (P5) 
 
“I think everything was relatively easy because I could use it on my phone on 
the go, so filling in the diary, if I’d forgotten to do it the night before I could do 
it on the train.” (P6) 
 
I mean for me it would have been really difficult I mean almost impossible to 
do the programme if I had to come here [to hospital] every week, and I think 
that has delayed me to ask for help in the past” (P1) 
 
1.2 Understanding the content 
All of the women commented on how they could understand or relate to the content of 
the Prezi. This was often in response to the interview question on comprehensibility, 
but it was also raised elsewhere. The women explained how they connected with the 95 
stories, the style of written language, and more generally with the simplicity of the 
content.  
 
“If someone is reading for the first time, especially a woman who is actually 
experiencing these kind of issues, it’s like, you feel like it’s helpful straight 
away it’s not really anything complicated, the language is really simple.” (P4) 
 
“I liked the stories, so it wasn’t just the information that I had to consume, but 
it was something more personal, so I could relate to some of the stories as 
well… it made it much easier to make sense in my head, instead of just 
reading through information and trying to take it on board.” (P2) 
 
“The  Prezi,  I  think  there  is  something  a  bit  more  grown-up  about  it  and 
because it starts with explaining it, it straight away doesn’t make you feel 
stupid or patronised which I think is important.” (P5) 
 
1.3 Negotiating privacy  
Only  three  women  commented  on  issues  of  privacy,  but  it  appeared  to  be  an 
important  issue  for  those  who  raised  it.  Opinions  on  privacy  were  somewhat 
divergent. P4 said she found it difficult to ensure the privacy of calls during work 
hours.  P5 and P6 found the trainers  difficult to conceal  at  home, but found other 
aspects of the programme, such as accessing it online and using anonymous codes 
enhanced a sense of privacy. Therefore, a mixed picture of privacy was found. 
 
 “Sometimes I end up standing on the street like in a quiet corner talking 
about inserting things and stuff and I really hope no-one can hear me.” (P4) 
 
“I think they’re [trainers] probably the hardest element because they’re the 
least subtle, private, you know when you live in a house with other people” 
(P5) 
  
“Because there were codes it didn’t really matter what I was writing down 
even if it was in public.” (P6) 96 
 
2.  Process of treatment 
Themes in this domain concentrated on the experience of following the programme, 
including  the  stepped  structure,  support  received  along  the  way  and  a  sense  of 
progress  throughout  treatment.  These  themes  were  not  clearly  linked  to  specific 
questions, but tended to be discussed in the context of acceptability. 
 
 
2.1 Steps to penetration 
Five women reported that they liked the progressive nature of the programme. They 
liked being able to work through the initial phases (Steps 1-3) before the penetration 
phase, explaining that it gave them time to prepare and build up skills to help them to 
feel ready.   
 
“I  thought  it  was  really  well  structured,  so  when  you  got  to  the  point  of 
starting to use the trainers, you had built very good foundations.” (P1) 
 
“I  liked  the  fact  that  it  gave  the  whole  thing,  the  reading  about  it,  the 
understanding of how it worked, the relaxation was important, so it wasn’t 
just focused on, you know the practical bit.” (P3) 
 
“What I liked was the way it built it up in stages, that I did at first initially think 
it was going to jump straight into things like trainers and stuff like that so. It 
was nice that I had time to progress.” (P6) 
 
2.2  Feeling supported  
All  of  the  women  commented  on  the  weekly  telephone  calls  being  supportive  or 
helpful. They reported that it was important to speak to someone with knowledge 
about the problem and who could help guide them through the programme at the right 
pace. They also said it felt as if they were not alone. Several women explained that 
whilst the Prezi offered more general information, the calls provided individualised 
support. 
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“You  really  need  someone  there  and  someone  who  also  knows,  their 
expertise, they can tell you try this or that.” (P1) 
 
“I think that helped a lot, it did, just because you know someone is there with 
you. I know it’s very personal problem, but you still need someone there.” 
(P2) 
 
 “I think that the value of the phone call is that it is tailored around what you 
are experiencing, so obviously there are always going to be things that don’t 
quite fit…so I think that it was really helpful to be able to talk to someone and 
say what was going on.” (P3) 
 
 
2.3  Frustration at progress  
Five of the six women reported that they had sometimes felt frustrated at the amount 
of  time  it  was  taking  to  progress  and/or  the  effort  that  was  required  to  see  an 
improvement (primarily in relation to trainer use). The women progressed at their own 
pace and were only advised not to move onto larger sizes if they were experiencing 
pain. The level of frustration appeared to be influenced by the amount of progress 
made, for example, P4 who showed the least improvement on penetration expressed 
the most amount frustration. Two women commented that when progress seemed 
slow, the diary helped them to reflect that overall progress was still being made. 
 
“Because it’s frustrating, you know you have to do it but sometimes I am so 
tired and sleepy, I am too tired for this today and sometimes it’s just being 
tired of being frustrated, it’s not very helpful.” (P4) 
 
“In the beginning I was a little bit inpatient to kind of, oh get on with this, 
what’s happening? And actually there was a lot of work you needed to do 
emotionally,  mentally,  and  also  you  know,  like  all  the  different  stages  of 
preparing,” (P1) 
 
“Sometimes, you know there would be moments where I was not succeeding 
as much as I thought I would be. I think that [diary] gave me the feeling that I 
was still making progress.”(P3) 98 
 
 
 
2.  Suggestions for improvement  
Women  were  asked  about  ways  in  which  they  might  improve  or  change  the 
programme. Common suggestions related to orienting the content of the Prezi, being 
given more information and having more clinician input. 
 
2.1. Easier way to navigate  
The Prezi software was not able to remember the last place the person viewed the 
programme. This meant that the women had to search through the content to find 
where they last were. Three women commented on this, and two suggested having 
software that could remember their last location or have bookmarks to help find the 
information more easily.  
 
“If they were just hyperlinks you could just click and it would jump to like the 
second step. Because I think if I remember correctly, it went back to the start 
and you had to keep clicking.” (P6) 
 
“If you have it in some kind of book format you can straight away find where 
you left it, you can go back to things, whereas with this one, or maybe I am 
just useless technologically, but I didn’t know how to do it so I had to kind of 
going like de de de [clicking] until I found the right bit.” (P1) 
 
2.2. More information 
Three women wanted more information included in the Prezi. Two women had sought 
additional information on the Kegel exercises; one mentioned using another resource 
to help with orgasm.  
 
“I think  maybe  once  I  looked  something  up  elsewhere. I  think  it was  the 
Kegel exercises I just wasn’t, I think it is just because it is a hard thing to 
explain, but I was just trying to make sure I was doing it right.” (P5) 
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“If there’s any way of making it more personal, so more stories that you could 
relate  to,  plus  more  information...there was  a book  I  used for, to try and 
make myself orgasm”. (P2) 
 
2.3. More clinician input  
Three women said that additional support could have been helpful in terms of the 
amount of clinical contact and the time necessary to complete the programme. 
 
“I think if someone actually approaches you or seeks help and they are still 
at this early stage they will need a lot more psychological support to work 
through the preliminary issues.” (P3) 
 
“Maybe you can give some support in this area [feeling frustrated], because I 
found this the most difficult thing and the thing that, maybe something you 
could help a little bit more in this particular area.” (P4) 
 
3.  Cognitive change  
The themes in this domain relate to cognitive changes that women identified as a 
consequence of the programme. They were asked to identify changes that occurred 
and were prompted to comment on how they related to particular elements of the 
programme. It was interesting that women talked mostly about cognitive, rather than 
the  behavioural  change,  the  latter  of  which  was  captured  by  the  quantitative 
outcomes.  
 
3.1.  Awareness of self 
Five  of  the  women  commented  on  how  they  had  become  more  aware  of  their 
reactions, both cognitively and physically. Women learnt to notice when they were 
tense or relaxed and this related to specific techniques in the programme (Kegels and 
relaxation). They also reported being more aware of thoughts linked to their fears of 
penetration.  Some  of  them  described  how  they  would  try  to  respond  to  these 
moments of awareness differently. P1 and P2 said that programme had helped them 
to notice difficulties they experienced with anxiety more generally.   100 
 
“It [Kegels] just helps you realise how much in control you can be of those 
muscles. In terms of the other relaxation exercises, I didn’t use those loads, 
but what I did learn was that in myself when was good to use them and when 
wasn’t good to use them” (P5) 
“It’s naturally coming into my head, all of the bad thoughts ‘it’s going to hurt’ 
or I naturally tense up. It is like a habit now. So the main thing for me is not 
just to relax but try and make positive thoughts out of negative.” (P2) 
 
“When I know we are about to have sex, I keep thinking in my head, kind of 
mentally freezes, like I don’t know if this is going to hurt or not, so I keep 
having to tell myself in my head ‘oh this is going to be fine, I can do this” (P6) 
 
3.2.  Normalising the problem 
Five women said that the programme had made them view vaginismus as a common 
or  more  manageable  problem.  Expectations  about  the  programme  being  helpful 
seemed  to  be  low  initially,  with  indications  that  vaginismus  was  seen  to  be  an 
unsolvable rare problem. After the programme, the problem seemed to be viewed as 
less overwhelming and manageable.  
  
“At the very beginning maybe I thought it was this like this terrible thing that 
no-one else in the world had, even if I knew. I think the programme has 
made me process  more the fact that other people,  maybe not many, but 
other people have the same problem.” (P3) 
 
“I honestly thought that something is wrong with me or the relationship… 
Where after reading through the programme, what vaginismus was, it made 
it sound much easier like it’s a small problem, I think 3% of women have it in 
the world, so I am not the only one, it’s treatable, and you don’t need any 
medicine or anything” (P2) 
 
“I didn’t feel like I’m part of, like I’m different, I knew that inside. But now I’m 
like no, I'm just completely normal. So it’s a huge thing for me” (P1) 
 
3.3.  Feeling more confident 101 
When asked about changes they had noticed in themselves, all of the women said 
they felt more confident. Confidence often related to interactions in their relationships, 
such  as,  approaching sexual  behaviours,  and  talking to  partners  about  what  they 
wanted  sexually.  Some  women  were  also  more  optimistic  about  the  future,  for 
example, more confident with the idea of starting new relationships and being able to 
tackle the problem again if it returns.   
 
“It gave me some confidence back that, I can do that…I didn’t really have 
much problem with them so it was kind of like this is something I can do and 
I will be able to do bigger sizes at some point. Definitely motivated me and 
gave me confidence that I can do that at all.” (P4) 
 
“I think it’s also made me more confident in being able to talk with a partner 
about things, things that are causing me pain, things that I don’t like or just 
anything  sexual.  Because  before  I  couldn’t  really  and  I  think  this  has 
encouraged me to do that.” (P6) 
 
“Now  I  see  people  and  I  think,  if  I  like  them,  oh  it  could  be  a 
relationship…whereas before I would probably get a bit more nervous if I like 
someone, because I would think if we get together I would have a problem” 
(P1) 
 
4.  Behavioural attributions to change  
The  programme  was  reported  to  decrease  avoidance  and  increase  approach 
behaviours; this is a change in itself, but was also attributed as the cause of the 
cognitive  changes  outlined  above.  Trainer  use  was  identified  as  the  most  difficult 
aspect of the programme, but one of the main contributors to change.  
 
4.1.  Approach from avoidance 
All six women commented on how the programme had encouraged them to approach 
the problem, whereas before they had been more inclined to avoid doing something 
about it. This is partly inherent in the programme, as it asks women to undertake 
exercises  and  face  the  problem.  Approach  behaviours  were  often  related  to  the 102 
clinical  support  and  monitoring  (diary  and  calls),  which  seemed  to  motivate  the 
women to engage with the programme. One woman (P4) said although she had used 
the trainers more, she had become more avoidant of sexual activities with partner, 
because she wanted to be comfortable using the trainers first. 
 
“It  helped  me  to  motivate  myself,  because  sometimes  when  you  have  a 
problem you try to avoid to handle it, even though it’s very important and you 
convince yourself that you need to go through this, sometimes you want to 
just not face it.” (P2) 
 
“If I was on my own, I could do that on my own probably, but it would be, I 
just like, sometimes you give up.” (P4) 
 
“Knowing that I had to write something down and that somebody would see 
it, kind of motivated me to do something during that day, because otherwise I 
would have probably been lazy.” (P6) 
 
4.2.  Trainers difficult but necessary 
All of the women reported that the trainers had been a main reason for change in the 
programme. This may be expected, because this is the stage where they directly 
faced the feared situation. The women described how they had realised trainers of 
increasing size could be inserted without pain. They also identified this as the most 
difficult  aspect  of  the  programme,  but  one  that  had  to  be  undertaken  in  order  to 
progress.  The  women  often  reported  that  they  were  willing  to  tolerate  some 
discomfort when using the trainers in order to reach their goals.  
 
“Maybe for me the biggest change was like trying these dilators, because it 
like as I said, you can talk about it, you can read about it but at the end of the 
day that’s not what is going to help.” (P4) 
 
“The trainers, although I think they took a bit of getting used to, which I had 
the opportunity to do before, I think there’s no other way around that and 
actually, I think they’re probably the hardest element.” (P5) 
 103 
“It  was  obviously  for  me  the  most  ground-breaking  one  was  the  trainers, 
because I thought ‘oh my God something can kind of come in there!” (P1) 
 
DISCUSSION 
The  effectiveness  and  acceptability  of  a  new  computerised  guided  self-help 
programme for vaginismus was evaluated on six women. A multiple case design was 
used to assess quantitative change over time, in addition to pre- and post- treatment 
outcome measures. Qualitative interviews were used to evaluate the programme’s 
acceptability and change experienced as a result of the programme.  
 
Summary of quantitative results 
Pain-related  fear  was  observed  to  reduce  over  the  course  of  the  programme.  A 
reliable improvement was found from baseline to end of treatment in all women, and a 
large  effect  size  was  comparable  to  previous  research  (ter  Kuile  et  al.,  2013). 
Changes in reported fear tended to be associated with exposure activity; a ≥50% 
reduction  in  pain-related  fear  occurred  in  all  women  after  commencement  of  the 
exposure  phase  and  strong  negative  correlations  between  fear  and  penetration 
suggest that these factors were associated.  
Successful penetration attempts were observed to increase over the course 
of the programme. A reliable improvement from baseline to the end of treatment was 
found in five women, and a large effect size was found in line with previous evidence 
(van Lankveld et al., 2006). Approximately three weeks into the programme, all of the 
women embarked on exposure using trainers, giving an indication of the time needed 
to  prepare  for  exposure.  By  the  end  of  treatment,  three  women  had  successful 
intercourse; one without a partner was successfully using her vibrator; and two had 
not  yet  attempted  intercourse.  Pain  on  penetration  was  observed  to  reduce  with 
successive penetration attempts; but, for most women, pain was low in intensity from 
the initial attempts, suggesting that tension was already minimised.  104 
No clear patterns of change were found on outcomes of generalised anxiety 
or relationship satisfaction.  
 
Summary of qualitative results 
Practically, participants found the programme easy to access, use and understand. 
There  was  inconsistency  regarding  privacy;  some  found  it  enhanced  a  sense  of 
privacy  (e.g.  having  information  online),  whereas  others  mentioned  difficulties 
concealing trainers and phone conversations.  
The  process  of  treatment  was  experienced  as  helpful  in  terms  of  its 
progressive nature (building up skills in preparation for exposure) and the support 
received  along  the  way.  The  clinical  contact  and  monitoring  of  activity  was 
experienced  as  having  a  motivational  influence.  There  was  some  experience  of 
progress being slower than expected, accompanied by feelings of frustration. 
In terms of the change identified, women became more aware of tension in 
their bodies and were able to identify negative thoughts attached to sexual activity. 
Their view of vaginismus seemed to change from being an untreatable problem to a 
common and manageable problem. Confidence was reported to improve in relation to 
sexual functioning and interpersonal behaviours more broadly. Behavioural change 
inherent in the programme were also identified as helpful; generally, moving from 
avoidance to approaching the problem, and specifically, the use of the trainers.  
 
To  help  conceptualise  a  more  inclusive  picture  of  the  computerised  vaginismus 
programme, a model has been developed (Figure 10) that includes both quantitative 
and qualitative findings. This is a hypothetical conceptual model and would need to 
be developed through further research. It includes the practical aspects of treatment 
that  were  found  to  be  acceptable  and  which  could  influence  initial  and  continued 
engagement with the programme. It identifies ongoing processes that might occur 
throughout treatment and which are likely to require the input of a clinician. Finally, it 105 
includes  changes  that  may  be  expected  as  the  programme  is  followed.  These 
changes  are  not  intended  to  reflect  a  sequential  order,  but  highlight  possible 
experiences along the journey of treatment.    
 
Figure 10: Model of vaginismus programme 
 
Theoretical explanations 
Quantitative  and  qualitative  findings  suggested  that  pain-related  fear  reduced  in 
conjunction  with  successful  penetration  experiences.  This  is  consistent  with 
behavioural models of vaginismus such as Wijma and Wijma’s (1997) model outlined 
in the introduction. Negative reinforcement (from avoidance) is removed as gradual 
exposure  provides  evidence  of  non-threatening  outcomes.  With  repetition,  the 
association between the conditioned stimulus (fearful anticipation of penetration) and 
the conditioned response (muscle tension/pain) is weakened. This model implies that 
pain-related fear reduces subsequent to exposure, which seemed to be the case in 
this study. However, for a minority of the women, pain-related fear started to reduce 
before exposure. This could relate to the pre-exposure phases of treatment and is 106 
supported by the ‘steps to penetration’ theme, in which women liked the fact they 
have time to learn skills in preparation for exposure. Such preparation is used when 
treating  other  anxiety-based  disorders  using  systematic  desensitisation,  equipping 
people with relaxation skills first to minimise fear during exposure (Wolpe, 1968).  
 
Penetration activities were inherent in the programme, but that did not guarantee their 
success. For example, three of the women had previously been recommended to use 
trainers or a vibrator without regular clinician input (see Table 4), but had only been 
partially successful in using these (this statement is supported by high pre-treatment 
pain  scores  and  the fact  they  were  still  seeking  help).  Therefore,  the programme 
seemed  to  offer  something  additional  that  encouraged  the  women  to  engage  in 
penetration activities more frequently and with more success.  
One  explanation  that  relates  to  the  ‘feeling  supported’  theme  from  the 
qualitative  analysis  is  that  the  clinical  input  received  throughout  the  programme 
motivated the women to engage with the exercises. Research suggests that having 
some  clinical  contact  (not  necessarily  face-to-face)  makes  a  difference  when 
compared with no contact at all. This has not been evidenced for vaginismus, but in 
an RCT of a computerised intervention for depression, weekly email contact from a 
therapist led to greater improvement in symptoms  (ES= 1.14), compared with  no 
additional  guidance  (ES=0.66;  Berger,  Hämmerli,  Gubser,  Andersson,  &  Caspar, 
2011). Even without clinical input the effect is large, and it would be interesting to see 
whether the vaginismus programme could be effective without any support.  
Another explanation for the success of penetration could be the frequency of 
activities  undertaken.  The  programme  asked  participants  to  engage  in  regular 
practice, and the theme ‘approach from avoidance’ demonstrated that women had 
previously  not  been  attending  to  the  problem.  A  behavioural  approach  would 
acknowledge that regular exposure is vital for the association between fear and pain 
to be weakened. Frequency of practice could also relate  to the support received, 107 
without which women may have been inclined to slip back into cycles of avoidance, 
particularly as most women reported that trainers were initially uncomfortable. This is 
analogous to treatment for other anxiety disorders that requires people to endure low 
levels of distress in order obtain disconfirmatory evidence of the feared outcome.  
Whilst some pain was experienced, scores tended to be low even on initial 
penetration attempts. This could be explained by the graded behavioural approach; 
women only moved onto larger trainers when they had used previous sizes with no 
pain  or  minimal  discomfort  (Abramowitz,  Deacon  & Whiteside,  2012).  If  pain  was 
intolerable,  women  would  be  at  risk  of  disengaging  with  the  trainers  (positive 
reinforcement from success  needed  to outweigh negative  reinforcement from  pain 
avoidance). Even when pain scores were low, a change of a little as 2 points on an 
11-point  pain  scale  has  been  found  to  be  clinically  meaningful  (Farrar,  Young, 
LaMoreaux, Werth & Poole, 2001); so what may appear to be a small change could 
be important to the patient.  
 
The finding that the programme was convenient (easy to access and fit into routine) 
highlights  the  importance  of  instant  and  flexible  access  to  resources.  This  could 
reflect the wider culture of internet-based help-seeking and fits with findings from a 
national survey that found the internet was used to access help with health concerns, 
because it was an easy and fast way to get information (Ybarra & Sunman, 2006). It 
seems  a  sensible  option  to  provide  information  online,  leaving  clinical  time  for 
personalised  support  the  internet  cannot  offer.  Whilst  the  programme  fostered 
convenience,  privacy  seemed  harder  to  achieve.  Face-to-face  contact  in  hospital 
settings enables privacy and confidentiality; in this programme, ensuring the privacy 
of phone calls was the responsibility of the patient. In addition, whilst the programme 
itself was all online (enhancing privacy), the trainers were necessary material objects 
that jeopardised privacy. Difficulties concealing trainers would be the same in routine 
clinical practice; it may be possible to exchange exposure using trainers for fingers 108 
(Mousavinasab & Farnoosh, 2003). Three participants suggested that they would like 
to be able to navigate the online content more easily and have additional information 
included in the programme; these suggestions could be integrated into future versions 
without difficulty. Three women also commented on wanting more clinical input. This 
is less easily changed, particularly if the intervention is found to be clinically and cost 
effective with minimal contact (research implications discussed below).  
 
Wider context  
It  is  useful  to  view  these  findings  within  the  wider  context  of  computerised 
programmes  for  physical  and  mental  health.  There  has  been  an  expansion  of 
systematic reviews examining the effectiveness of internet-based interventions; many 
of which have found equal effects between online and face-to-face interventions for 
chronic  pain  (Cuipers,  van  Straten  &  Andersson,  2008),  sexual  health  knowledge 
(Bailey  et  al.,  2010),  and  anxiety  and  depression  (Andrews  et  al.,  2010).  So  far, 
internet-based options seem a promising alternative to face-to-face treatment. Others 
have evaluated individual components of successful internet-based interventions for 
health;  a  meta-analysis  revealed  that  the  inclusion  of  more  behaviour  change 
techniques  increased  effectiveness  (Webb,  Joseph,  Yardley  &  Michie,  2010). 
Behaviour  change  techniques  were  purposefully  integrated  into  the  current 
programme (see interventions section), providing a measurable way to compare it to 
a wide range of other behavioural interventions (Abraham & Michie, 2008). With a 
future of internet-based healthcare ahead, it is vital to understand the psychological 
components of change as well as the size of clinical effects.  
 
Strengths  
Use  of  single  case  methodology  enabled  an  in-depth  evaluation  of  a  novel 
intervention, supported by qualitative findings. Multiple repeated outcomes allowed for 
the  examination  of subtle processes of change  through  components of treatment, 
which  are  not  usually  detectable  using  pre-post  analyses.  This  methodology  may 109 
seem  far-removed  from  the  gold  standard  randomised  designs;  but  an  increasing 
amount  of  research  is  drawing  on  single  case  methodology  and  attempting  to 
integrate randomisation methods to enhance credibility (Kratochwill & Levin, 2010).  
 
Limitations  
The multiple case design used could have been improved. Firstly, the baseline phase 
helps to determine change at the introduction of an intervention. This study had a 
mean baseline of eight days, which is disproportionate to the intervention duration 
and may not have been long enough for scores to stabilise. Increasing the baseline 
duration  would  allow  for  stabilisation  and  strengthen  conclusions  about  causality. 
Secondly, a follow-up period was not included, which is important for evaluating the 
longer-term impact of the programme. Ter Kuile et al., (2009) used a similar single-
case  A-B  design  and  had  a  follow-up  period  of  12  weeks,  in  which  successful 
penetration continued to increase post-treatment. Follow-up data would have been 
particularly useful to review the progress of P4 & P5 who continued to use the trainers 
and work towards intercourse. Finally, as the programme was designed to be flexible, 
half of the women chose not to do  Step 3, body awareness. This diminished the 
opportunity to observe patterns across all phases of the programme.  
 
Participants were asked to rate pain on scale of 0-10 in order to obtain regular data 
without burdening them with lengthy questionnaires. This was helpful in terms of data 
gathering, but the reliability of the scores was more problematic. Pre-treatment pain 
ratings were estimates of penetration pain, which for some women were not recent 
experiences (ranging from 3 days to 8 months). The test-retest reliability coefficient 
taken from ter Kuile et al., (2007) had a stability period of three weeks, which means 
four of the six women in this study fall outside of that window for their baseline pain 
ratings. Moreover, pain scores were compared across activities; it could be argued 
that, for example, whilst a vibrator is similar in size with a penis, emotional factors 110 
associated with intercourse makes these activities impossible to compare. The PEQ 
was also limited in its measurement, assessing penetration over a four week period 
and potentially missing subtle changes in behaviour. Adapting the PEQ to measure a 
two week period could have helped to detect more discrete change and allowed for a 
better observation of penetration in line with the individual’s activity throughout the 
programme.  
 
Outcomes in this study may have been biased by researcher allegiance, which occurs 
when a researcher holds a preference for a particular treatment (Leykin & DeRubeis, 
2009). Researcher allegiance is associated with factors such as having authorship of 
the intervention and believing a certain therapeutic approach is superior to others 
(Gaffan, Tsaousis, & Kemp-Wheeler, 1995). Bias occurs when allegiance influences 
the outcomes of research. It is difficult to know whether this study was biased by 
allegiance,  but as the author and sole delivering clinician of the intervention, it is 
possible the findings would have been different if the programme was delivered by 
someone  less  invested  in  the  research.  This  posed  a  particular  risk  during  the 
interviews, as participants were being asked by the delivering clinician about their 
experiences.  This  is  likely  to  have  influenced  their  expression  of  negative 
experiences; having an independent researcher would have helped to minimise bias 
of favourable outcomes in the qualitative data. 
 
Whilst this  research  did  not  explicitly  exclude  women  with  complex  mental  health 
difficulties or abusive histories, it is unknown whether such participants would benefit 
from the programme. For example, women who have experienced abuse may need 
more time to reflect on its impact and women in non-consensual relationships would 
be  prioritised for  help  with  domestic  violence.  Adaptions  could  be made for  more 
complex  presentations,  such  as  face-to-face  sessions  in  addition  to  programme 
access, but this would need to be supported by research.  111 
 
Research and clinical implications  
It is not the intention of a multiple case design to generalise to the target population; 
however, with data from only 6 women, the wider effectiveness of the vaginismus 
programme  is  unknown.  A  larger  controlled  trial  could  provide  a  more  substantial 
effectiveness evaluation. It would be helpful for the trial to include several arms as 
follows:  1)  guided  computerised  self-help,  2)  unguided  computerised  self-help,  3) 
guided bibliotherapy, and 4) unguided bibliotherapy. These arms would help to control 
for the mode of delivery (computerised versus paper information), as well as the level 
of clinical input (with or without guidance). It might be expected that more clinical 
input improves efficacy, in which case it would also be interesting to include a face-to-
face arm, to assess the quality of the interaction. If more clinical input is found to 
increase efficacy, then a cost-effectiveness analysis could help to determine whether 
additional  resource  is  worth  the  change  in  treatment  outcome.  It  might  also  be 
hypothesised that a computerised mode would be more accessible, but it is difficult to 
know whether this would impact on the overall efficacy of the intervention.   
It  would  be  helpful  to  use  additional  quantitative  outcomes  to  evaluate 
change identified by the current study’s qualitative findings. For example, a measure 
of  confidence  and  other  behavioural  changes  (such  as  interactions  within  the 
relationship) could help to assess the wider impact of the intervention. With a larger 
dataset it would be interesting to consider whether relationship satisfaction mediates 
the effectiveness of the intervention. The programme is very much focused on the 
woman holding responsibility for change, but sexual dysfunction is rarely detached 
from  interpersonal  issues.  Therefore,  the  development  of  a  programme  which 
emphasises  systemic  couples  work  could  be  another  avenue  of  research.  The 
programme  was  also  focused  on  penetration;  opening  the  content  up  to  address 
sexual  wellbeing  more  generally,  including  aspects  such  as  desire,  arousal  and 
orgasm, could provide a more holistic intervention. A measure of sexual function that 112 
considers all of these factors, such as the Female Sexual Function Index (Rosen et 
al., 2000), could be used to assess effectiveness.  
 
If the computerised programme for vaginismus is clinically comparable (in terms of 
the size of effect achieved) and more economical (resource required) with face-to-
face interventions, women could be offered the choice between routine care and the 
computer programme, or possibly a mix of the two. The programme could help to 
save resources, because it is paperless, and time is saved due to outcomes being 
collected online and the intervention being conducted using brief telephone contact. 
Waiting-lists  could  be  reduced,  as  clinicians  could  make  three  contacts  per  hour 
instead  of  one.  The  flexibility  of  the  programme  could  also  help  more  women  to 
access treatment for vaginismus, in particular for women for whom time is a practical 
barrier to help-seeking or for those who are embarrassed to speak face-to-face about 
sexual  issues.  As  we  move  towards  a  future  of  online  healthcare,  validating  and 
implementing such interventions in real clinical settings should be a priority. 
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Part 3: Critical Appraisal 121 
Psychotherapy research today is scrutinised on numerous indicators of quality and 
bias. These indicators have tended to focus on design methodology, but biases can 
also  arise  from  interpersonal  factors,  such  as  the  allegiance  of  the  researcher. 
Allegiance occurs when the researcher believes that active components and effects 
of one treatment surpass those of another. This belief can lead to a bias in research 
if  ‘investigators’  allegiances  are  responsible  for  the  advantages  found  for  their 
preferred treatments’ (Leykin  &  DeRubeis,  2009,  p56).  Links  between  allegiance 
and outcome have been demonstrated empirically, though the mechanisms behind 
these links are less clear. In this critical appraisal, I will reflect on my own allegiance 
to my research on vaginismus and try to establish potential biases that occurred.  
  
Before highlighting potential problems with allegiance, it should be noted that within 
the history of psychology, allegiance may have been necessary for the development 
of theory and intervention. One could argue that paradigm shifts were borne out of 
allegiance; tension between theories and theorists helped to drive research forward. 
Dissatisfaction  with  one  psychological  approach  led  to  the  breakdown  and 
displacement  of  allegiance.  For  example,  in  Miller’s  reflections  on  the  cognitive 
revolution,  he  reports,  ‘When  I  became  dissatisfied  at  Harvard  between  B.F. 
Skinner’s  strict  behaviorism  and  S.S.  Stevens’  psychophysics,  I  turned  to  Jerry 
Bruner’s social psychology, and in 1960 that led to the creation at Harvard of the 
Center for Cognitive Studies.’ (Miller, 2003, p142). It seems impossible to have no 
allegiance in such a diverse field of science; however, it should be recognised as a 
potential biasing factor in research. 
In a review of reviews, 30 meta-analyses comprising 1248 primary studies 
on psychological treatment were examined for allegiance effects (Munder, Brütsch, 
Leonhart, Gerger & Barth, 2013). Seven percent of the variance in outcome was 
explained by research allegiance (r=0.26). This association was maintained when 
controlling  for  treatment  type,  patient  population  and  setting.  Interestingly,  the 122 
review  also  examined  allegiance  of  the  authors  of  the  included  meta-analyses. 
Strong allegiance to the concept of research allegiance was found to moderate the 
outcomes  of  primary  studies  (r=0.39).  Therefore,  even  when  trying  to  evaluate 
allegiance impartially, researchers are still at risk of holding influential biases.  
Quality measures have been developed to try to capture levels of allegiance. 
I came across these when undertaking my literature review, in which I chose to 
implement a measure developed by Gaffan, Tsaousis, & Kemp-Wheeler (1995). It 
attempts  to  assess  several  domains  of  allegiance,  including:  citing  previous 
research  that  supports  a  particular  treatment;  discussing  the  superiority  of  a 
particular treatment; including a lengthy description of a particular treatment; having 
authorship  of  a  treatment;  and  researching  only  one  active  treatment  condition. 
When applying this quality measure to my own research I discovered that I met 
criteria for bias on all domains! This was somewhat of a surprise as it suggested 
that  my  research  was  high  risk  in  terms  of  allegiance  bias.  Recognition  of  this 
encouraged me to reflect on the domains of allegiance in relation to my research.  
 
Authorship  
As there were no available computerised self-help programmes for vaginismus I set 
about  writing  the  programme  content,  drawing  on  the  available  literature.  The 
theoretical  concepts  were  grounded  in  evidence,  but  the  content  and  visual 
presentation  were  influenced  by  my  own  writing  style,  creative  vision  and 
understanding of theory. For example, the programme had fictional vignettes and 
hand-drawn  anatomical diagrams,  the  inclusion  of  which  enhanced  the sense of 
ownership and personalisation. Other individualised components of the programme, 
such as the use of online resources (links to websites, audio files), also contributed 
to a feeling that the programme was in some way unique. After the  programme 
content was drafted it was sent to specialists for comment and revised accordingly. 
This process helped me to feel more confident about the quality of the product and 123 
the desire to claim ownership of it. Taking these reflections into account, there is no 
doubt that I held a strong allegiance to the programme, but in what ways could 
authorship have biased my research?  
 
It  has  been  suggested  that  the  delivery  of  treatment  may  differ  depending  on 
whether the delivering clinician is also the author (McLeod, 2009). Being familiar 
with the content might improve the quality of delivery compared to clinicians who 
may  be  less  knowledgeable  about  the  specific  intervention.  Could  authoring  the 
content have improved my delivery of the programme or could a more experienced 
psychologist have delivered the programme effectively without knowing the content 
in its entirety? Knowing the content is surely not enough to deliver it in an optimal 
therapeutic  way;  this  would  undermine  a  fundamental  premise  of  clinical 
psychology, which is the therapeutic relationship between clinician and patient. But 
being  familiar  with  the  content  could  indeed  help  the  patient  access  the  right 
information and increase competence in the delivering clinician. It has been argued 
that to know whether or not a treatment is effective, it should be implemented by 
‘people who know what they are doing’, together with independent monitoring of the 
treatment (Hollon, 1999, p110). This argument fits with what is expected from real 
clinical practice; trained clinicians delivering specialist interventions with supervision. 
Without formal evaluation, it is difficult to know how well I delivered the vaginismus 
programme and whether this was influenced by allegiance.  
 
Hollon (1999) commented that authorship of treatment in itself does not necessarily 
map  on  to  one’s  clinical  work.  For  example,  a  doctor  may  be  interested  in 
developing  CBT-based  treatment  for  pain,  but  clinically  works  in  a  medical 
framework.  Vaginismus  is  commonly  treated  in  genitourinary  medicine  clinic;  a 
multidisciplinary  setting  with  primary  diagnostic  input  received  from  medical 
professionals. My external supervisor was a gynaecologist and there were times in 124 
the research when I asked him whether the source of a participant’s pain could be 
better  explained  by  an  underlying  chronic  pain  condition,  such  as  provoked 
vestibulodynia.  For  other  participants  I  also  wondered  whether  longer  term 
psychological help in the form of couple’s therapy (as opposed to CBT model) could 
be more helpful. Researching in an MDT setting and keeping an open mind to the 
biological  factors  and  alternative  therapeutic  models  was  a  useful  way  to  inhibit 
strong allegiance effects.  
 
Being the author of the vaginismus programme certainly influenced my desire for 
the  intervention  to  work  effectively  and  be  acceptable  to  patients. I  was  able  to 
identify clues to my own authorship bias when listening to the clinical interviews at 
the end of treatment. Participants did not know that I had written the programme, 
although some of my responses to their experiences were noticeably confirming. 
For example, I observed that in several of my responses I said ‘that’s good’, or ‘I’m 
glad’. Even though I was consciously trying to be impartial, I had built up therapeutic 
rapport with the participants over the course of the programme and it felt invalidating 
not  to  comment  on  their  progress.  Therefore,  being  both  the  author  of  the 
programme and the interviewer could have certainly created a bias.  
 
Superiority 
Prior to this research, I worked in a sexual health setting and implemented CBT-
informed treatment for sexual dysfunction; so it was my opinion that this was the 
most  appropriate  form  of  help  for  vaginismus.  Undertaking  my  literature  review 
confirmed this belief, as it was the most commonly evaluated treatment (Melnik, 
Hawton & McGuire, 2012). Moreover, it was the only model in which I was trained to 
manage  sexual  dysfunction;  other  less  commonly  used  approaches  such  as 
hypnotherapy  or  psychodynamic  psychotherapy  were  outside  my  therapeutic 
repertoire.  125 
 
The belief that one treatment is superior to another has been called the ‘Mecca 
effect’ (Shaw, 1999). This is not to say that one treatment is always seen to be the 
best, but one modality may be seen as superior for a certain client group, such as 
dialectical behaviour therapy for borderline personality disorder or CBT for worry. 
Often, clinicians will have a preferred modality of treatment and it is reasonable to 
assume that the Mecca effect and allegiance are strongly connected. What is less 
clear is whether this effect always leads to biased outcomes.  
In  my  study,  it  could  be  hypothesised  that  the  outcomes  were  more 
successful than if I had attempted to deliver a psychodynamic-informed approach, 
but this would be attributable to my own limitations as a psychologist rather than the 
influence of allegiance. Research has shown that behavioural activation delivered 
by  generic  mental  health  staff  with  minimal  training  can  result  in  good  clinical 
outcomes  in  depression  (Ekers,  Richards,  McMillan,  Bland  &  Gilbody,  2011).  It 
would be  interesting to know  whether similar  outcomes could be obtained if the 
vaginismus programme was delivered by staff who did not view CBT as superior. 
This could help to alleviate allegiance effects and minimise bias. Bearing in mind 
that  the  telephone  calls  drew  on  fundamental  therapeutic  techniques  (not  just 
problem-solving), the capacity to do ‘therapy’ could also influence the effectiveness 
of the intervention. In any clinical setting, patients and staff would expect treatment 
to be delivered by a professional who is skilled in that area, so why not in research 
too?  Shaw  (1999)  argued  that  if  outcomes  are  improved  by  allegiance,  then  it 
should  be fostered to  achieve  better  results for  all  patients. The  practicalities  of 
fostering  allegiance,  however,  are  difficult  to  imagine,  and  the  notion  of 
brainwashing may come to mind! But if a measure of individual allegiance (including 
beliefs  about  superiority)  was  developed,  it  could  be  a  useful  starting  point  to 
examine  allegiance  effects  in  practice.  So  far,  allegiance  indicators  have  been 
applied to entire studies, rather than to individual researchers or clinicians.  126 
 
 
Investment in outcome 
Investment in outcome was not defined as a separate item in Gaffan et al.’s (1995) 
measure, but I think it is closely linked to authorship and superiority beliefs. We 
know from the evidence that allegiance is positively associated with outcome, but 
the mechanism behind this is less well understood. It has been suggested that if 
someone is invested in a particular outcome, s/he will draw on the knowledge s/he 
has to fit with the desired result (Markman & Hirt, 2002). Applying this concept to my 
research, when a participant was finding it difficult to insert one of the trainers, I 
would draw on all the behavioural techniques I had used previously to help them 
achieve that outcome. But would I have been so invested in helping them achieve 
penetration  behaviour  if  it  was  not  one  of  my  main  outcome  measures?  If  my 
primary outcome was relationship satisfaction, maybe I would have focused on the 
dynamics between the  couple and drawn more on systemic theory instead. The 
primary outcomes were selected in accordance to the CBT model in use, suggesting 
influences of treatment superiority from the outset.  
The process of setting up and seeing research through from beginning to 
end is often costly; whether it is time, effort, financial or emotional cost. For me, I 
think the emotional cost influenced my sense of allegiance most. Feelings of fear 
and  frustration  often  accompanied  the  research  process,  and  the  idea  that  the 
programme would fail evoked such emotions. Without this emotional investment, 
would I have been so attentive to the success of the treatment? This is likely to 
reflect  the  feelings  of  other  researchers,  who  have  a  strong  desire  certain  for 
outcomes.  This  is  represented  more  generally  in  publication  bias;  neutral  and 
negative outcomes are far less likely to be published, indicating that findings do not 
represent  the  desires  of  researchers.  Interestingly,  experimental  research  has 
examined desirability in relation to games, and a quote from one article summed up 127 
my experience well: ‘knowing that one has a lot of money riding on the outcome of a 
game might cause greater attention to evidence supporting the desirable outcome, 
but  might  also  cause  restraint  of  one’s  stated  optimism  as  a  way  of  protecting 
oneself from disappointment’ (p113, Krizan & Windschitl, 2007). Although I did not 
have  real  money  riding  on  the  outcome,  I  felt  that  I  paid  more  attention  to  the 
evidence that supported a successful outcome, rather than contemplating that the 
treatment  might  be  unsuccessful  for  some  people.  I  also  found  that  I  was  on 
occasion telling myself ‘it doesn’t matter’ about the findings as long as I had my 
data, which could have been my attempt to protect myself from disappointment. Of 
all the aspects of allegiance, I think for me, emotional investment could be the most 
powerful driver of bias. 
 
Sole active condition 
Another indicator of research allegiance identified by Gaffan et al., (1995) was the 
inclusion of a sole active treatment condition. This criterion may be more applicable 
to larger RCTs where it is common to have at least one active treatment group. In 
my  research  project  it  would  have  been  difficult  to  arrange  a  second  treatment 
condition.  However,  the  fact  I  had  not  thought  to  compare  the  programme  with 
another  condition  or  even  a  control  made  me  wonder  about  the  influence  of 
allegiance. On reflection, I could have collected pre- and post- treatment outcomes 
from women who opted for of routine care (face-to face treatment) or from those 
who were waiting to be assessed.  
 
Citing supporting research  
Undertaking a systematic review on psychological treatments for vaginismus helped 
me  to  identify  treatment  modalities  other  than  CBT  (in  RCTs  only),  such  as 
hypnotherapy. But I realised the good quality evidence for alternative treatments 
was thin.  I realised that I had not considered  non-RCT research into  alternative 128 
treatments which led me to run a quick search of non-CBT, non-RCT research for 
vaginismus.  I  discovered  empirical  investigations  and  reviews  from  a  range  of 
theoretical  backgrounds,  including  psychodynamic,  humanistic,  and 
behavioural/biofeedback (Barnes, Bowman & Cullen, 1984; Hiller, 1996; Kleinplatz, 
1998). However, this literature tended to be small-scale, outdated, and had not been 
replicated or supported by more robust evidence. Without the CBT literature, few 
good studies remained. Therefore, on this domain of allegiance bias, I would argue 
that  citing  evidence  to  support  a  CBT  approach  was  a  true  reflection  of  the 
evidence-base, rather than a biased inclusion of specific research. Re-visiting my 
superiority  beliefs,  it  seems  in  the  case  of  vaginismus,  CBT  may  be  viewed  as 
‘Mecca’ for a reason.  
 
Implications and recommendations  
Although allegiance and attempts to moderate its effects are starting to be evaluated 
as indicators of quality research, as it stands, most researchers still consciously or 
unconsciously  bias  their  findings  by  holding  an  allegiance  to  certain  treatments. 
Without guidance or recommendations to inform researchers about how bias can be 
minimised, they will continue to be at risk of influencing outcomes. Reflecting on my 
own research allegiance has impacted on the way that I would approach research in 
the future. I have developed several recommendations: 
1.  It  would  be  advantageous  to  develop  a  clinician’s  manual  for  the  vaginismus 
programme.  This  would  diminish  effects  of  authorship  and  help  to  standardise 
treatment.  It  would  also  allow  for  adherence  checks,  which  would  be  useful  for 
monitoring differences in the quality of delivery.  
2.  Use of a manual would not be enough to eliminate allegiance effects; for example, a 
clinician with a pre-existing preference for CBT might be more prone to allegiance 
bias than a clinician who has a pre-existing preference for systemic therapy. It could 
be  helpful  if  researchers  (as  with  qualitative  indicators  of  credibility)  state  their 129 
position  on  the  research  in  hand,  for  example,  what  psychological  models  they 
practice in and whether they expect certain results. A measurement of individual 
clinician  preferences  could  be  useful  to  understand  effectiveness  research  in 
relation to allegiance; but to my knowledge, there is no such validated questionnaire 
in psychological research. 
3.  When developing and evaluating a treatment programme, it would be desirable for 
the  author  not  to  deliver  it  directly  to  patients.  This  is  already  an  established 
methodological criterion in RCTs, in which studies that use independent researchers 
and attempt to mask investigators are seen to be more robust. Training clinicians to 
deliver  the  programme  could  still  pose  an  allegiance  bias,  but  less  so  than  the 
author  or  researchers  themselves.  The  aforementioned  manual  would  allow  the 
programme  to  be  delivered  by  independent  professionals  (e.g.  nurses, 
gynaecologists,  psychologists),  who  would  be  less  invested  in  the  programme’s 
success. This also applies to outcome collection (questionnaires and interviews), 
which should be obtained independently where possible. 
4.  It would be useful to compare the programme to another treatment condition to see 
whether CBT is more effective than other approaches. This could help challenge 
allegiance to CBT. As the evidence for vaginismus is limited largely to behavioural 
and cognitive approaches it would be difficult to create distinct treatment conditions, 
particularly  because  treatments  such  as  hypnotherapy  and  psychodynamic 
approaches  may  not  be  amenable  to  a  computerised  format.  But  different 
components  could  be  evaluated,  for  example,  one  condition  could  be  purely 
behavioural  (exposure),  one  could  be  cognitive  (thought-focused),  and  another 
could be CBT (integration of techniques). This could help to demonstrate differences 
in treatment effectiveness and help to identify mechanisms of change.  
5.  It would be helpful for a reliable and valid measure to be developed, that could 
quantify and help to predict levels of bias in response to allegiance variables. For 
example, a quasi-randomised trial may be classified as high risk on selection bias 130 
and the results of the research would be treated with caution. So what if a study was 
at high risk of allegiance bias? Would we treat it with the same level of caution and 
interpret the results accordingly? Allegiance information could be corroborated with 
other biasing factors to get a more complete assessment of risk. Further research in 
this area could help to clarify these questions. 
 
Final thoughts 
This reflection has led me to identify several improvements that could help to reduce 
allegiance  bias.  But to reduce  is  not to  eliminate,  and  allegiance  will  always  be 
inescapable to some extent. Allegiance in psychological treatment is entwined with 
the therapeutic relationship; so removing allegiance bias is more complex and could 
be argued to be unethical. I believe allegiance can be advantageous in guiding the 
progression of psychological research, which is often driven by positive experiences 
of implementing treatments with patients. I would not have been driven to develop 
and evaluate a CBT-based programme for vaginismus if I had not experienced the 
successful implementation of this approach beforehand. If we want to encourage 
psychologists to undertake research alongside their clinical work, the likelihood is 
they will evaluate treatments that they feel enthusiastic about.  131 
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Appendix 1: Literature review search strings 
OVID (Psychinfo, EMBASE & Medline) 
1.  vaginismus or dyspareunia or superficial dyspareunia or vestibulodynia or 
vulv* vestibulitis or vulvodynia  
2.  provoked adj3 (vulvodynia or vestibulodynia) 
3.  localised adj3 (vulvodynia or vestibulodynia) 
4.  sexual dysfunction and vagin* and pain* 
5.  sexual dysfunction and female and pain* 
6.  1-5 
7.  random or randomi*ation or randomi*ed controlled trial or control* trial or 
controlled clinical trial or random* adj 2 (trial or allocate* or assign* or 
sampl*) 
8.  clinical adj2 trial 
9.  double blind or single blind  
10. 7-10 
11. 6 and 10 
 
 
CINHAL 
1.  CINAHL; (vaginismus OR dyspareunia OR superficial AND dyspareunia OR 
vestibulodynia OR vulv* AND vestibulitis OR vulvodynia)  
2.  CINAHL; (provoked AND vulvodynia OR provoked AND vestibulodynia OR 
localised AND vulvodynia OR localised AND vestibulodynia)  
3.  CINAHL; (sexual AND dysfunction AND vagin* AND pain) 
4.  CINAHL; (sexual AND dysfunction AND female AND pain*)  
5.  CINAHL; 11 OR 12 OR 13 OR 14 
6.  CINAHL; (random OR randomi*ation OR randomi*ed AND controlled AND 
trial OR controlled AND clinical AND trial)  
7.  CINAHL; (random* AND trial OR random* AND allocate* OR random* AND 
assign* OR random* AND sampl*)  
8.  CINAHL; (clinical AND trial OR double AND blind OR single AND blind)  
9.  CINAHL; 16 OR 17 OR 18 
10. 20. CINAHL; 15 AND 19 134 
Appendix 2: Literature review forest plots 
Analysis 1.1  
Comparison: CBT versus medical treatment  
Outcome: General pain post-treatment  
 
 
Analysis 1.2 
Comparison: CBT versus medical treatment  
Outcome: pain on intercourse post-treatment 
 
Analysis 1.3 
Comparison: CBT versus medical treatment  
Outcome: pain on intercourse 6 months follow-up 
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Analysis 1.4 
Comparison: CBT versus medical treatment  
Outcome: sexual functioning post-treatment  
 
 
 
Analysis 1.5 
Comparison: CBT versus medical treatment  
Outcome: sexual functioning 6 month follow-up 
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Analysis 2.1 
Comparison: Behavioural versus medical treatment  
Outcome: symptom elimination follow-up  
 
Analysis 3.1 
Comparison: CBT versus other psychological treatment   
Outcome: pain on intercourse post-treatment  137 
 
 
Analysis 3.2 
Comparison: CBT versus other psychological treatment   
Outcome: pain on intercourse follow-up 
 
Analysis 3.3 
Comparison: CBT versus other psychological treatment   
Outcome: sexual functioning post-treatment  138 
 
 
 
 
Analysis 3.4 
Comparison: Cognitive & Behavioural versus other psychological treatment   
Outcome: sexual anxiety post-treatment  
 
 
Analysis 4.1 139 
Comparison: Bibliotherapy versus control   
Outcome: sexual frequency post-treatment  
 
 
 
Analysis 4.2 
Comparison: CBT and behavioural treatment versus waitlist 
Outcome: Pain on intercourse 
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Analysis 4.3 
Comparison: CBT and behavioural treatment versus waitlist 
Outcome: Fear of intercourse 141 
Appendix 3: Empirical study Patient Information Sheet 
 
 
St Mary’s Hospital 
 Imperial College Healthcare NHS Trust 
Jefferiss Wing 
 Praed Street, London  
W2 1NY 
0203 3121697 
 
Participant information and consent sheet 
A computerised self-help guide for women with vaginismus 
(Students research project) 
You are being invited to take part in a research study. Before you decide it is important for 
you to understand why the research is being done and what it will involve.  Please take time 
to read the following information. Ask us if anything is unclear or if you would like more 
information. Take time to decide whether or not you want to take part. 
 
What is the purpose of the study? 
The purpose of this study is to see whether a computerised self-help programme can help 
women with vaginismus. 
 
Vaginismus is associated with vaginal pain and difficulties with penetration, which can be a 
very distressing problem. Estimates suggest that approximately 1% of women in the general 
population have this condition. Treatment for vaginismus is usually delivered face-to-face by 
a sexual health specialist. At the moment, there is no computer-based version of treatment, 
but there is an increasing demand for help to be available online. Therefore, this study is 
going to examine whether a computerised self-help programme can be a helpful way to treat 
vaginismus.  
 
Why have I been chosen? 
Women who have been given a diagnosis of vaginismus will be asked whether or not they 
want to take part in the study. This is because the programme has been designed 
specifically to help women experiencing this problem. We are aiming to get about 10 women 
to take part in this research.  
 
Do I have to take part? 
It is up to you whether or not to take part. If you do decide to take part you will be given this 
information sheet to keep and be asked to sign a consent form. If you decide to take part you 
are still free to withdraw at any time and without giving a reason. A decision to withdraw at 
any time, or a decision not to take part, will not affect the standard care you receive.  
   
What will happen to me if I take part? 
If you decide to take part you will meet with the researcher who will explain how the 
computer programme works and what you need to do.  A week after this meeting, you will be 
given access to the programme and you work through it at home. You will have weekly 
telephone contacts (10-15 minutes) with the researcher to help guide you through the 
programme which is estimated to last 6-8 weeks. 
 
The computerised programme will involve reading information and following instructions. 
There will be a number of things you will need to do including:  142 
reading about vaginal pain; learning relaxation techniques and exercises for muscle control; 
exploring your body; working towards penetration by containing trainers (smooth plastic 
objects of different sizes) in your vagina whilst feeling relaxed. The exercises will take 
different amounts of time to complete; some will take 5 minutes and others 30 minutes. 
However, it is up to you how much you do each day. 
 
You will be asked to complete a daily diary to monitor what activities you are doing each day 
and your experiences of fear and pain (if any). This will also be completed online and should 
not take more than a minute per day. There will also be some short questionnaires that you 
will be asked to complete before and after the programme.  
 
At the end it would be helpful to hear about your experiences of using the programme and so 
the researcher will ask you some questions about what you found helpful or not so helpful 
over the telephone. This should take about 20-30 minutes. This will be recorded and 
transcribed after which the recording will be deleted.  
 
Travel expenses will not be reimbursed for journeys made to the clinic. 
 
What are the alternative treatments? 
You have the option to choose whether or not you want to take part in this study. If you do 
not want to then you can have routine treatment which involves the same exercises, but 
instead you will be meeting weekly face-to-face with a sexual health specialist.  
 
What are the potential benefits? 
Previous research has shown that similar programmes for women with vaginismus have 
helped them to achieve sexual intercourse. This study is hoping to produce similar 
outcomes, aiming to help women have vaginal penetration, reduce fear of vaginal 
penetration and reduce pain on penetration. 
 
What if something goes wrong? 
We do not anticipate any risk will come to the women who take part in this study.  
As vaginismus is associated with pain on attempted penetration, it is likely that there will be 
some physical discomfort during the training phase of the programme. This is a normal part 
of treatment although the idea is to minimise your pain or discomfort as much as possible. 
This will be done by introducing the training element slowly and only when you have 
completed the previous steps and feel ready.  
 
If you wish to complain, or have any concerns about any aspect of the way you have been 
approached or treated by members of staff you may have experienced due to your 
participation in the research, National Health Service or UCL complaints mechanisms are 
available to you. Please ask your research doctor if you would like more information on this.  
 
In the unlikely event that you are harmed by taking part in this study, compensation may be 
available.  
 
If you suspect that the harm is the result of the Sponsor’s (University College London) or the 
hospital's negligence then you may be able to claim compensation.  After discussing with the 
researcher, please make the claim in writing to Amanda Williams who is the Chief 
Investigator for the research and is based at University College London. The Chief 
Investigator will then pass the claim to the Sponsor’s Insurers, via the Sponsor’s office. You 
may have to bear the costs of the legal action initially, and you should consult a lawyer about 
this. 
 
What happens when the research study stops? 
After the programme has finished, you will be given the choice of coming for a follow-up 
appointment with the researcher if you think the intervention has not been successful or if 
you need some additional support, to discuss your needs. A decision will then be made 
about how the genitourinary clinic can provide further support or whether a referral will be 
made to a more appropriate service. You will continue to have access to the computerised 
programme. 143 
 
Will my taking part in this study be confidential? 
In compliance with the Data Protection Act 1998, all information which is collected about you 
during the course of the research will be kept strictly confidential. Any information about you 
which leaves the hospital will have your name and address removed so that you cannot be 
recognised from it. Your GP will be notified of your participation in this study with your 
permission if you consent.  
 
What will happen to the results of the research? 
The results of the study will be retained and written up as part of Doctoral research 
conducted at University College London (UCL). The UCL Records Office maintains archived 
records in a safe and secure off site location. Access to stored records is strictly controlled. 
The results could also be published in a journal. Any publication will uphold confidentiality 
and anonymity.  
 
Who is organising the research? 
This study is being conducted as part of Doctoral research at University College London, 
with approval from Imperial Healthcare NHS Trust. 
 
020 3312 6754   
Main contacts for research 
If you are interested in taking part in this research, you can: 
  Contact the researcher (Esther Flanagan) directly via telephone or email (details 
below) 
  Inform the healthcare worker you are currently seeing that you would like to take part 
in the study, and then the researcher will contact you to arrange a meeting. 
  Or, contact Esther Flanagan or David Goldmeier to find out more about this research 
before you decide whether or not you want to take part. 
 
Ms Esther Flanagan 
Trainee Clinical Psychologist 
@nhs.07454 535 521 
 
Dr David Goldmeier 
Consultant Gynaecologist  
 
For independent advice and support you can contact Imperial College patient advice and 
liaison service (PALS) offers help, support, information and advice to patients and their 
relatives, friends and carers. 
PALS  
Ground floor, Clarence wing, St Mary’s Hospital,  
London W2 1NY  
020 3312 7777 
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Appendix 4: Empirical paper consent form 
 
St Mary’s Hospital 
 Imperial College Healthcare NHS Trust 
Jefferiss Wing 
 Praed Street, London  
W2 1NY 
0203 3121697 
 
INFORMED CONSENT FORM 
Title of Project: A computerised self-help guide for women with vaginismus 
Principal Investigator: Amanda Williams 
 
Please initial each box once you have read it. 
I confirm that I have read and understood the subject information 
sheet dated for the above study and have had the opportunity to ask 
questions which have been answered fully.  
 
I understand that my participation is voluntary and I am free to 
withdraw at any time, without giving any reason, without my medical 
care or legal rights being affected.  
 
I understand that sections of any of my medical notes may be looked 
at by the researcher or regulatory authorities where it is relevant to my 
taking part in this research. I give permission for these individuals to 
access my records that are relevant to this research. 
 
I understand that the interview at the end of the programme will be 
recorded 
 
I agree to the referrer/GP being informed of my participation in the 
study 
 
I agree to take part in the above study.   
 
Name of Participant       Signature       Date  
 
_________________________ ________________ ________________  
Name of Person taking     Signature       Date 
Consent 
 
_________________________ ________________ ________________  
Name of Principal Investigator   Signature       Date 145 
Appendix 5: Empirical paper screenshot of programme 146 
Appendix 6: Empirical paper ethics approval letter   
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Appendix 7: Empirical paper Primary Endpoint Questionnaire 
 
1  In the last 4 weeks, have you had sexual intercourse (full vaginal penetration by a 
penis) 
  Not attempted 
  Attempted, but not successful 
  Attempted, and sometimes successful 
  Attempted, and always successful 
2  In the last 4 weeks, have you inserted a finger into your vagina? 
  Not attempted 
  Attempted, but not successful 
  Attempted, and sometimes successful 
  Attempted, and always successful 
3  In the last 4 weeks, have you inserted two fingers into your vagina? 
  Not attempted 
  Attempted, but not successful 
  Attempted, and sometimes successful 
  Attempted, and always successful 
4  In the last 4 weeks, has your partner inserted their finger into your vagina? 
  Not attempted 
  Attempted, but not successful 
  Attempted, and sometimes successful 
  Attempted, and always successful 
5  In the last 4 weeks, has your partner inserted two fingers into your vagina? 
  Not attempted 
  Attempted, but not successful 
  Attempted, and sometimes successful 
  Attempted, and always successful 
6  In the last 4 weeks, have you inserted any other object into your vagina? 
  Not attempted 
  Attempted, but not successful 
  Attempted, and sometimes successful 
  Attempted, and always successful 
7  In the last 4 weeks, has your partner inserted any object into your vagina? 
  Not attempted 
  Attempted, but not successful 
  Attempted, and sometimes successful 
  Attempted, and always successful 
  End of the questionnaire. Thank you for completing the questionnaire. 
 152 
Appendix 8: Empirical paper interview schedule 
  
Questions 2-4 aim to elicit information on acceptability. Questions 1, 5-9 aimed to 
elicit information on change and are derived from Elliott, Slatick & Urman’s (2001) 
Client Change Interview. 
 
1.  What was your overall experience of using the computer programme?  
 
2.  Likeability  
What did you like or dislike about the programme? Please give 
examples. For example, what kinds of things were appealing and helpful or 
what kind of things were hindering, unhelpful, negative or disappointing?  
 
3.  Usability 
How easy or difficult was it to use the programme? For example, 
accessing and filling out information online, finding way around the content.  
 
4.  Comprehensibility 
How easy or difficult was it to understand the programme? For example, 
understanding the language used in the programme, following the 
instructions. 
 
5.  Were there things in the therapy which were difficult or painful but still 
OK or perhaps helpful? What were they? 
 
6.  What changes, if any, have you noticed in yourself since the 
programme started? (For example, are you doing, feeling, or 
thinking differently from the way you did before? What specific ideas, if any, 
have you gotten from therapy so far, including ideas about yourself or other 
people? Have any changes been brought to your attention by other people?) 
Prompt for both positive and negative changes. 
 
7.  Is there anything that you wanted to change that hasn’t since therapy 
started? 
 
8.  Attributions 
In general, what do you think has caused these various changes? In 
other words, what do you think might have brought them 
about? (Including things both outside of therapy and in therapy) Prompt for 
specific parts of the programme. 
 
9.  Suggestions 
Do you have any suggestions for us, regarding the research or the 
therapy? Do you have anything else that you want to tell me? 
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Appendix 9: Empirical paper qualitative annotation  
 
 